{"transactions":[{"id":1398034,"issuer":{"id":8372,"kind":"organization","name":"iSpecimen Inc."},"owners":[{"id":81268,"kind":"person","name":"Dhaliwal Avtar","position":1,"cik":"0002038577","reported_name":"Dhaliwal Avtar","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option","published_at":"2024-09-30T06:02:04.000Z","date":"2024-09-25","kind":"grant","planned":false,"acquired":true,"shares":168,"price":5.12,"value":860.16,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents stock options granted to the reporting person on September 25, 2024, pursuant to the Issuer's Amended and Restated Stock Incentive Plan, and reflects the Issuer's 20-for-1 reverse stock split effective as of 4:30 p.m., Eastern Time, on September 13, 2024. The stock options vest in respect to 84 shares on each of September 30, 2024 and December 31, 2024."}],"balance_after":168,"derivative":{"exercise_price":5.12,"expiration_date":"2034-09-24","underlying":"Common Stock","underlying_shares":168},"source":{"system":"sec-edgar","filing":"0001104659-24-103842","document":"tm2425111-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2038577/000110465924103842/tm2425111-4_4seq1.xml","form_type":"4"}},{"id":1398565,"issuer":{"id":8372,"kind":"organization","name":"iSpecimen Inc."},"owners":[{"id":48377,"kind":"person","name":"Paolone Richard","position":1,"cik":"0002038402","reported_name":"Paolone Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option","published_at":"2024-09-27T23:20:37.000Z","date":"2024-09-25","kind":"grant","planned":false,"acquired":true,"shares":168,"price":5.12,"value":860.16,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents stock options granted to the reporting person on September 25, 2024, pursuant to the Issuer's Amended and Restated Stock Incentive Plan, and reflects the Issuer's 20-for-1 reverse stock split effective as of 4:30 p.m., Eastern Time, on September 13, 2024. The stock options vest in respect to 84 shares on each of September 30, 2024 and December 31, 2024."}],"balance_after":168,"derivative":{"exercise_price":5.12,"expiration_date":"2034-09-24","underlying":"Common Stock","underlying_shares":168},"source":{"system":"sec-edgar","filing":"0001104659-24-103806","document":"tm2425111-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2038402/000110465924103806/tm2425111-6_4seq1.xml","form_type":"4"}},{"id":1398556,"issuer":{"id":8372,"kind":"organization","name":"iSpecimen Inc."},"owners":[{"id":24682,"kind":"person","name":"Field Katharyn","position":1,"cik":"0002029888","reported_name":"Field Katharyn","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option","published_at":"2024-09-27T23:19:16.000Z","date":"2024-09-25","kind":"grant","planned":false,"acquired":true,"shares":168,"price":5.12,"value":860.16,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents stock options granted to the reporting person on September 25, 2024, pursuant to the Issuer's Amended and Restated Stock Incentive Plan, and reflects the Issuer's 20-for-1 reverse stock split effective as of 4:30 p.m., Eastern Time, on September 13, 2024. The stock options vest in respect to 84 shares on each of September 30, 2024 and December 31, 2024."}],"balance_after":168,"derivative":{"exercise_price":5.12,"expiration_date":"2034-09-24","underlying":"Common Stock","underlying_shares":168},"source":{"system":"sec-edgar","filing":"0001104659-24-103805","document":"tm2425111-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2029888/000110465924103805/tm2425111-5_4seq1.xml","form_type":"4"}},{"id":1508594,"issuer":{"id":8372,"kind":"organization","name":"iSpecimen Inc."},"owners":[{"id":90805,"kind":"person","name":"Ross Andrew L.","position":1,"cik":"0001857013","reported_name":"Ross Andrew L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option","published_at":"2024-05-20T19:26:45.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0.53,"value":5300.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents stock options granted to the reporting person on January 2, 2024, pursuant to the Issuer's Amended and Restated Stock Incentive Plan. The stock options vest respect to 2,500 shares on each of March 31, 2024, June 30, 2024, September 30, 2024 and December 31, 2024."}],"balance_after":33525,"derivative":{"exercise_price":0.53,"expiration_date":"2034-01-01","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001104659-24-063361","document":"tm2414962-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1558569/000110465924063361/tm2414962-5_4seq1.xml","form_type":"4"}},{"id":1508596,"issuer":{"id":8372,"kind":"organization","name":"iSpecimen Inc."},"owners":[{"id":90807,"kind":"person","name":"Graham Elizabeth Ames","position":1,"cik":"0001916581","reported_name":"Graham Elizabeth Ames","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option","published_at":"2024-05-20T19:23:59.000Z","date":"2024-03-21","kind":"grant","planned":false,"acquired":true,"shares":8340,"price":0.28,"value":2335.2,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents stock options granted to the reporting person on March 21, 2024, pursuant to the Issuer's Amended and Restated Stock Incentive Plan. The stock options vest respect to 2,085 shares on each of March 31, 2024, June 30, 2024, September 30, 2024 and December 31, 2024."}],"balance_after":8340,"derivative":{"exercise_price":0.28,"expiration_date":"2034-03-20","underlying":"Common Stock","underlying_shares":8340},"source":{"system":"sec-edgar","filing":"0001104659-24-063359","document":"tm2414962-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1558569/000110465924063359/tm2414962-3_4seq1.xml","form_type":"4"}},{"id":1508595,"issuer":{"id":8372,"kind":"organization","name":"iSpecimen Inc."},"owners":[{"id":90806,"kind":"person","name":"Gullans Steven R. Ph.D.","position":1,"cik":"0001571997","reported_name":"Gullans Steven R. Ph.D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option","published_at":"2024-05-20T19:21:37.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0.53,"value":5300.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents stock options granted to the reporting person on January 2, 2024, pursuant to the Issuer's Amended and Restated Stock Incentive Plan. The stock options vest respect to 2,500 shares on each of March 31, 2024, June 30, 2024, September 30, 2024 and December 31, 2024."}],"balance_after":33525,"derivative":{"exercise_price":0.53,"expiration_date":"2034-01-01","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001104659-24-063356","document":"tm2414962-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1558569/000110465924063356/tm2414962-2_4seq1.xml","form_type":"4"}},{"id":1509151,"issuer":{"id":8372,"kind":"organization","name":"iSpecimen Inc."},"owners":[{"id":90826,"kind":"person","name":"Mock Theresa L","position":1,"cik":"0001870249","reported_name":"Mock Theresa L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option","published_at":"2024-05-20T15:25:10.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0.53,"value":5300.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents stock options granted to the reporting person on January 2, 2024, pursuant to the Issuer's Amended and Restated Stock Incentive Plan. The stock options vest respect to 2,500 shares on each of March 31, 2024, June 30, 2024, September 30, 2024 and December 31, 2024."}],"balance_after":16672,"derivative":{"exercise_price":0.53,"expiration_date":"2034-01-01","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001104659-24-063360","document":"tm2414962-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1870249/000110465924063360/tm2414962-4_4seq1.xml","form_type":"4"}},{"id":1508680,"issuer":{"id":8372,"kind":"organization","name":"iSpecimen Inc."},"owners":[{"id":90814,"kind":"person","name":"Brooks John L. III","position":1,"cik":"0001343930","reported_name":"Brooks John L. III","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option","published_at":"2024-05-20T15:18:53.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0.53,"value":5300.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents stock options granted to the reporting person on January 2, 2024, pursuant to the Issuer's Amended and Restated Stock Incentive Plan. The stock options vest respect to 2,500 shares on each of March 31, 2024, June 30, 2024, September 30, 2024 and December 31, 2024."}],"balance_after":33525,"derivative":{"exercise_price":0.53,"expiration_date":"2034-01-01","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001104659-24-063354","document":"tm2414962-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1343930/000110465924063354/tm2414962-1_4seq1.xml","form_type":"4"}},{"id":1779815,"issuer":{"id":8372,"kind":"organization","name":"iSpecimen Inc."},"owners":[{"id":109667,"kind":"person","name":"Bielak Benjamin","position":1,"cik":"0001857054","reported_name":"Bielak Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Info Officer & Secretary"}}],"security":"Common Stock","published_at":"2023-09-15T20:23:45.000Z","date":"2023-09-14","kind":"purchase","planned":false,"acquired":true,"shares":18000,"price":0.72,"value":12960.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects an open market purchase of shares of the Issuer's common stock by the Reporting Person."}],"balance_after":84348,"source":{"system":"sec-edgar","filing":"0001104659-23-101210","document":"tm2326233-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1558569/000110465923101210/tm2326233-1_4seq1.xml","form_type":"4"}},{"id":1871672,"issuer":{"id":8372,"kind":"organization","name":"iSpecimen Inc."},"owners":[{"id":112896,"kind":"person","name":"Curley Tracy","position":1,"cik":"0001857028","reported_name":"Curley Tracy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, CFO and Treasurer"}}],"security":"Common Stock","published_at":"2023-06-01T21:56:08.000Z","date":"2023-05-31","kind":"purchase","planned":false,"acquired":true,"shares":4400,"price":1.25,"value":5500.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reflects an open market purchase of shares of the Issuer's common stock by the Reporting Person."},{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects an open market purchase of shares of the Issuer's common stock by the Reporting Person."}],"balance_after":49541,"source":{"system":"sec-edgar","filing":"0001104659-23-067152","document":"tm2317620-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1558569/000110465923067152/tm2317620-1_4seq1.xml","form_type":"4"}},{"id":1888423,"issuer":{"id":8372,"kind":"organization","name":"iSpecimen Inc."},"owners":[{"id":113385,"kind":"person","name":"Basile Joseph J.","position":1,"cik":"0001954843","reported_name":"Basile Joseph J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-17T16:39:07.000Z","date":"2023-01-01","kind":"grant","planned":false,"acquired":true,"shares":63,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reflects shares of common stock issued to the Reporting Person upon vesting and settlement of restricted stock units (\"RSUs\") on March 31, 2023, which RSUs were awarded to the Reporting Person as of January 1, 2023, subject to the terms and conditions set forth in the award of such RSUs by the Issuer to the Reporting Person pursuant to a Restricted Stock Unit Award Agreement."},{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects shares of common stock issued to the Reporting Person upon vesting and settlement of restricted stock units (\"RSUs\") on March 31, 2023, which RSUs were awarded to the Reporting Person as of January 1, 2023, subject to the terms and conditions set forth in the award of such RSUs by the Issuer to the Reporting Person pursuant to a Restricted Stock Unit Award Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The RSUs were awarded as compensation to the Reporting Person for his service as a director of the Company."}],"balance_after":63,"source":{"system":"sec-edgar","filing":"0001104659-23-061742","document":"tm2315065-7_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1558569/000110465923061742/tm2315065-7_4seq1.xml","form_type":"4"}},{"id":1888424,"issuer":{"id":8372,"kind":"organization","name":"iSpecimen Inc."},"owners":[{"id":113386,"kind":"person","name":"Mullan Jill","position":1,"cik":"0001857039","reported_name":"Mullan Jill","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-17T16:34:44.000Z","date":"2023-01-01","kind":"grant","planned":false,"acquired":true,"shares":92,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reflects shares of common stock issued to the Reporting Person upon vesting and settlement of restricted stock units (\"RSUs\") on March 31, 2023, which RSUs were awarded to the Reporting Person as of January 1, 2023, subject to the terms and conditions set forth in the award of such RSUs by the Issuer to the Reporting Person pursuant to a Restricted Stock Unit Award Agreement."},{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects shares of common stock issued to the Reporting Person upon vesting and settlement of restricted stock units (\"RSUs\") on March 31, 2023, which RSUs were awarded to the Reporting Person as of January 1, 2023, subject to the terms and conditions set forth in the award of such RSUs by the Issuer to the Reporting Person pursuant to a Restricted Stock Unit Award Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The RSUs were awarded as compensation to the Reporting Person for his service as a director of the Company."}],"balance_after":246318,"source":{"system":"sec-edgar","filing":"0001104659-23-061740","document":"tm2315065-5_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1558569/000110465923061740/tm2315065-5_4seq1.xml","form_type":"4"}},{"id":1888421,"issuer":{"id":8372,"kind":"organization","name":"iSpecimen Inc."},"owners":[{"id":113384,"kind":"person","name":"Ianelli Christopher","position":1,"cik":"0001857027","reported_name":"Ianelli Christopher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-17T16:33:04.000Z","date":"2023-01-01","kind":"grant","planned":false,"acquired":true,"shares":92,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reflects shares of common stock issued to the Reporting Person upon vesting and settlement of restricted stock units (\"RSUs\") on March 31, 2023, which RSUs were awarded to the Reporting Person as of January 1, 2023, subject to the terms and conditions set forth in the award of such RSUs by the Issuer to the Reporting Person pursuant to a Restricted Stock Unit Award Agreement."},{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects shares of common stock issued to the Reporting Person upon vesting and settlement of restricted stock units (\"RSUs\") on March 31, 2023, which RSUs were awarded to the Reporting Person as of January 1, 2023, subject to the terms and conditions set forth in the award of such RSUs by the Issuer to the Reporting Person pursuant to a Restricted Stock Unit Award Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The RSUs were awarded as compensation to the Reporting Person for his service as a director of the Company."}],"balance_after":425451,"source":{"system":"sec-edgar","filing":"0001104659-23-061739","document":"tm2315065-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1558569/000110465923061739/tm2315065-3_4seq1.xml","form_type":"4"}},{"id":1888420,"issuer":{"id":8372,"kind":"organization","name":"iSpecimen Inc."},"owners":[{"id":90805,"kind":"person","name":"Ross Andrew L.","position":1,"cik":"0001857013","reported_name":"Ross Andrew L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-17T16:27:33.000Z","date":"2023-01-01","kind":"grant","planned":false,"acquired":true,"shares":125,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reflects shares of common stock issued to the Reporting Person upon vesting and settlement of restricted stock units (\"RSUs\") on March 31, 2023, which RSUs were awarded to the Reporting Person as of January 1, 2023, subject to the terms and conditions set forth in the award of such RSUs by the Issuer to the Reporting Person pursuant to a Restricted Stock Unit Award Agreement."},{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects shares of common stock issued to the Reporting Person upon vesting and settlement of restricted stock units (\"RSUs\") on March 31, 2023, which RSUs were awarded to the Reporting Person as of January 1, 2023, subject to the terms and conditions set forth in the award of such RSUs by the Issuer to the Reporting Person pursuant to a Restricted Stock Unit Award Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The RSUs were awarded as compensation to the Reporting Person for his service as a director of the Company."}],"balance_after":1326340,"source":{"system":"sec-edgar","filing":"0001104659-23-061737","document":"tm2315065-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1558569/000110465923061737/tm2315065-2_4seq1.xml","form_type":"4"}},{"id":1888422,"issuer":{"id":8372,"kind":"organization","name":"iSpecimen Inc."},"owners":[{"id":90806,"kind":"person","name":"Gullans Steven R. Ph.D.","position":1,"cik":"0001571997","reported_name":"Gullans Steven R. Ph.D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-17T16:25:57.000Z","date":"2023-01-01","kind":"grant","planned":false,"acquired":true,"shares":125,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reflects shares of common stock issued to the Reporting Person upon vesting and settlement of restricted stock units (\"RSUs\") on March 31, 2023, which RSUs were awarded to the Reporting Person as of January 1, 2023, subject to the terms and conditions set forth in the award of such RSUs by the Issuer to the Reporting Person pursuant to a Restricted Stock Unit Award Agreement."},{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects shares of common stock issued to the Reporting Person upon vesting and settlement of restricted stock units (\"RSUs\") on March 31, 2023, which RSUs were awarded to the Reporting Person as of January 1, 2023, subject to the terms and conditions set forth in the award of such RSUs by the Issuer to the Reporting Person pursuant to a Restricted Stock Unit Award Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The RSUs were awarded as compensation to the Reporting Person for his service as a director of the Company."}],"balance_after":3250,"source":{"system":"sec-edgar","filing":"0001104659-23-061736","document":"tm2315065-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1558569/000110465923061736/tm2315065-1_4seq1.xml","form_type":"4"}},{"id":1888579,"issuer":{"id":8372,"kind":"organization","name":"iSpecimen Inc."},"owners":[{"id":90814,"kind":"person","name":"Brooks John L. III","position":1,"cik":"0001343930","reported_name":"Brooks John L. III","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-17T12:37:19.000Z","date":"2023-01-01","kind":"grant","planned":false,"acquired":true,"shares":125,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reflects shares of common stock issued to the Reporting Person upon vesting and settlement of restricted stock units (\"RSUs\") on March 31, 2023, which RSUs were awarded to the Reporting Person as of January 1, 2023, subject to the terms and conditions set forth in the award of such RSUs by the Issuer to the Reporting Person pursuant to a Restricted Stock Unit Award Agreement."},{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects shares of common stock issued to the Reporting Person upon vesting and settlement of restricted stock units (\"RSUs\") on March 31, 2023, which RSUs were awarded to the Reporting Person as of January 1, 2023, subject to the terms and conditions set forth in the award of such RSUs by the Issuer to the Reporting Person pursuant to a Restricted Stock Unit Award Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The RSUs were awarded as compensation to the Reporting Person for his service as a director of the Company."}],"balance_after":3250,"source":{"system":"sec-edgar","filing":"0001104659-23-061741","document":"tm2315065-6_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1343930/000110465923061741/tm2315065-6_4seq1.xml","form_type":"4"}},{"id":2022259,"issuer":{"id":8372,"kind":"organization","name":"iSpecimen Inc."},"owners":[{"id":117037,"kind":"person","name":"Lawrence Margaret H.","position":1,"cik":"0001857015","reported_name":"Lawrence Margaret H.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-02-11T00:45:14.000Z","date":"2022-10-01","kind":"grant","acquired":true,"shares":625,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares underlying certain restricted stock units (\"RSUs\"), each of which is a contingent right to receive one share of common stock at settlement subject to the terms and conditions set forth in the award of such RSUs by the Company to the Reporting Person pursuant to a Restricted Stock Unit Award Agreement (the \"RSU Agreement\"). The RSUs vests in one installment, on December 31, 2022, subject to the terms and conditions set forth in the RSU Agreement. 625 RSUs were settled for shares of common stock on December 31, 2022, and the Reporting Person was issued 625 shares of common stock."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying certain restricted stock units (\"RSUs\"), each of which is a contingent right to receive one share of common stock at settlement subject to the terms and conditions set forth in the award of such RSUs by the Company to the Reporting Person pursuant to a Restricted Stock Unit Award Agreement (the \"RSU Agreement\"). The RSUs vests in one installment, on December 31, 2022, subject to the terms and conditions set forth in the RSU Agreement. 625 RSUs were settled for shares of common stock on December 31, 2022, and the Reporting Person was issued 625 shares of common stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The RSUs were awarded as compensation to the Reporting Person for his service as a director of the Company."}],"balance_after":3125,"source":{"system":"sec-edgar","filing":"0001104659-23-018759","document":"tm236233-5_5seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1558569/000110465923018759/tm236233-5_5seq1.xml","form_type":"5"}},{"id":2022258,"issuer":{"id":8372,"kind":"organization","name":"iSpecimen Inc."},"owners":[{"id":117036,"kind":"person","name":"Scholl George H.","position":1,"cik":"0001857026","reported_name":"Scholl George H.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-02-11T00:44:16.000Z","date":"2022-10-01","kind":"grant","acquired":true,"shares":625,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares underlying certain restricted stock units (\"RSUs\"), each of which is a contingent right to receive one share of common stock at settlement subject to the terms and conditions set forth in the award of such RSUs by the Issuer to the Reporting Person pursuant to a Restricted Stock Unit Award Agreement (the \"RSU Agreement\"). 625 RSUs vested in one installment on December 31, 2022 and were settled on January 3, 2023, subject to the terms and conditions set forth in the RSU Agreement and as a result, 625 shares of common stock were issued to the Reporting Person."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying certain restricted stock units (\"RSUs\"), each of which is a contingent right to receive one share of common stock at settlement subject to the terms and conditions set forth in the award of such RSUs by the Issuer to the Reporting Person pursuant to a Restricted Stock Unit Award Agreement (the \"RSU Agreement\"). 625 RSUs vested in one installment on December 31, 2022 and were settled on January 3, 2023, subject to the terms and conditions set forth in the RSU Agreement and as a result, 625 shares of common stock were issued to the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The RSUs were awarded as compensation to the Reporting Person for his service as a director of the Company."}],"balance_after":3125,"source":{"system":"sec-edgar","filing":"0001104659-23-018757","document":"tm236233-4_5seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1558569/000110465923018757/tm236233-4_5seq1.xml","form_type":"5"}},{"id":2022257,"issuer":{"id":8372,"kind":"organization","name":"iSpecimen Inc."},"owners":[{"id":90805,"kind":"person","name":"Ross Andrew L.","position":1,"cik":"0001857013","reported_name":"Ross Andrew L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-02-11T00:43:22.000Z","date":"2022-10-01","kind":"grant","acquired":true,"shares":625,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares underlying certain restricted stock units (\"RSUs\"), each of which is a contingent right to receive one share of common stock at settlement subject to the terms and conditions set forth in the award of such RSUs by the Issuer to the Reporting Person pursuant to a Restricted Stock Unit Award Agreement (the \"RSU Agreement\"). 625 RSUs vested in one installment on December 31, 2022 and were settled on January 3, 2023, subject to the terms and conditions set forth in the RSU Agreement and as a result, 625 shares of common stock were issued to the Reporting Person."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying certain restricted stock units (\"RSUs\"), each of which is a contingent right to receive one share of common stock at settlement subject to the terms and conditions set forth in the award of such RSUs by the Issuer to the Reporting Person pursuant to a Restricted Stock Unit Award Agreement (the \"RSU Agreement\"). 625 RSUs vested in one installment on December 31, 2022 and were settled on January 3, 2023, subject to the terms and conditions set forth in the RSU Agreement and as a result, 625 shares of common stock were issued to the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The RSUs were awarded as compensation to the Reporting Person for his service as a director of the Company."}],"balance_after":1326215,"source":{"system":"sec-edgar","filing":"0001104659-23-018756","document":"tm236233-3_5seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1558569/000110465923018756/tm236233-3_5seq1.xml","form_type":"5"}},{"id":2022256,"issuer":{"id":8372,"kind":"organization","name":"iSpecimen Inc."},"owners":[{"id":90806,"kind":"person","name":"Gullans Steven R. Ph.D.","position":1,"cik":"0001571997","reported_name":"Gullans Steven R. Ph.D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-02-11T00:42:27.000Z","date":"2022-10-01","kind":"grant","acquired":true,"shares":625,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares underlying certain restricted stock units (\"RSUs\"), each of which is a contingent right to receive one share of common stock at settlement subject to the terms and conditions set forth in the award of such RSUs by the Issuer to the Reporting Person pursuant to a Restricted Stock Unit Award Agreement (the \"RSU Agreement\"). 625 RSUs vested in one installment on December 31, 2022 and were settled on January 3, 2023, subject to the terms and conditions set forth in the RSU Agreement and as a result, 625 shares of common stock were issued to the Reporting Person."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying certain restricted stock units (\"RSUs\"), each of which is a contingent right to receive one share of common stock at settlement subject to the terms and conditions set forth in the award of such RSUs by the Issuer to the Reporting Person pursuant to a Restricted Stock Unit Award Agreement (the \"RSU Agreement\"). 625 RSUs vested in one installment on December 31, 2022 and were settled on January 3, 2023, subject to the terms and conditions set forth in the RSU Agreement and as a result, 625 shares of common stock were issued to the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The RSUs were awarded as compensation to the Reporting Person for his service as a director of the Company."}],"balance_after":3125,"source":{"system":"sec-edgar","filing":"0001104659-23-018755","document":"tm236233-2_5seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1558569/000110465923018755/tm236233-2_5seq1.xml","form_type":"5"}},{"id":2022370,"issuer":{"id":8372,"kind":"organization","name":"iSpecimen Inc."},"owners":[{"id":90814,"kind":"person","name":"Brooks John L. III","position":1,"cik":"0001343930","reported_name":"Brooks John L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-02-10T19:41:19.000Z","date":"2022-10-01","kind":"grant","acquired":true,"shares":625,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares underlying certain restricted stock units (\"RSUs\"), each of which is a contingent right to receive one share of common stock at settlement subject to the terms and conditions set forth in the award of such RSUs by the Issuer to the Reporting Person pursuant to a Restricted Stock Unit Award Agreement (the \"RSU Agreement\"). 625 RSUs vested in one installment on December 31, 2022 and were settled on January 3, 2023, subject to the terms and conditions set forth in the RSU Agreement and as a result, 625 shares of common stock were issued to the Reporting Person."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying certain restricted stock units (\"RSUs\"), each of which is a contingent right to receive one share of common stock at settlement subject to the terms and conditions set forth in the award of such RSUs by the Issuer to the Reporting Person pursuant to a Restricted Stock Unit Award Agreement (the \"RSU Agreement\"). 625 RSUs vested in one installment on December 31, 2022 and were settled on January 3, 2023, subject to the terms and conditions set forth in the RSU Agreement and as a result, 625 shares of common stock were issued to the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The RSUs were awarded as compensation to the Reporting Person for his service as a director of the Company."}],"balance_after":3125,"source":{"system":"sec-edgar","filing":"0001104659-23-018754","document":"tm236233-1_5seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1343930/000110465923018754/tm236233-1_5seq1.xml","form_type":"5"}},{"id":2050457,"issuer":{"id":8372,"kind":"organization","name":"iSpecimen Inc."},"owners":[{"id":113384,"kind":"person","name":"Ianelli Christopher","position":1,"cik":"0001857027","reported_name":"Ianelli Christopher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option","published_at":"2023-01-19T23:32:41.000Z","date":"2023-01-06","kind":"exercise","acquired":false,"shares":845,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents the stock options that were vested on the date of termination of employment of the Reporting Person and will expire if not exercised by the Reporting Person before January 22, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Represents remaining granted stock options across all grants."}],"balance_after":10000,"derivative":{"exercise_price":1,"expiration_date":"2023-01-22","underlying":"Common Stock","underlying_shares":845},"source":{"system":"sec-edgar","filing":"0001104659-23-005104","document":"tm233905-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1558569/000110465923005104/tm233905-3_4seq1.xml","form_type":"4"}},{"id":2050456,"issuer":{"id":8372,"kind":"organization","name":"iSpecimen Inc."},"owners":[{"id":113384,"kind":"person","name":"Ianelli Christopher","position":1,"cik":"0001857027","reported_name":"Ianelli Christopher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option","published_at":"2023-01-19T23:32:41.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":10000,"price":1.41,"value":14100.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Represents stock options granted to the reporting person on January 3, 2023, pursuant to the Issuer's Amended and Restated Stock Incentive Plan.  The stock options vest with respect to 2,500 shares on each of March 31, 2023, June 30, 2023, September 30, 2023 and December 31, 2023."}],"balance_after":10845,"derivative":{"exercise_price":1.41,"expiration_date":"2033-01-03","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001104659-23-005104","document":"tm233905-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1558569/000110465923005104/tm233905-3_4seq1.xml","form_type":"4"}},{"id":2050455,"issuer":{"id":8372,"kind":"organization","name":"iSpecimen Inc."},"owners":[{"id":113384,"kind":"person","name":"Ianelli Christopher","position":1,"cik":"0001857027","reported_name":"Ianelli Christopher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-19T23:32:41.000Z","date":"2023-01-06","kind":"exercise","acquired":true,"shares":845,"price":1,"value":845.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Acquisition of shares of common stock by the Reporting Person upon the exercise of stock options."}],"balance_after":425359,"source":{"system":"sec-edgar","filing":"0001104659-23-005104","document":"tm233905-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1558569/000110465923005104/tm233905-3_4seq1.xml","form_type":"4"}},{"id":2050460,"issuer":{"id":8372,"kind":"organization","name":"iSpecimen Inc."},"owners":[{"id":113386,"kind":"person","name":"Mullan Jill","position":1,"cik":"0001857039","reported_name":"Mullan Jill","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option","published_at":"2023-01-19T21:04:53.000Z","date":"2023-01-17","kind":"exercise","acquired":false,"shares":66637,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents the stock options that were vested on the date of termination of employment of the Reporting Person and will expire if not exercised by the Reporting Person before January 22, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Represents remaining granted stock options across all grants."}],"balance_after":10000,"derivative":{"exercise_price":1,"expiration_date":"2023-01-22","underlying":"Common Stock","underlying_shares":66637},"source":{"system":"sec-edgar","filing":"0001104659-23-004999","document":"tm233905-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1558569/000110465923004999/tm233905-2_4seq1.xml","form_type":"4"}},{"id":2050459,"issuer":{"id":8372,"kind":"organization","name":"iSpecimen Inc."},"owners":[{"id":113386,"kind":"person","name":"Mullan Jill","position":1,"cik":"0001857039","reported_name":"Mullan Jill","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-19T21:04:53.000Z","date":"2023-01-17","kind":"exercise","acquired":true,"shares":66637,"price":1,"value":66637.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Acquisition of shares of common stock by the Reporting Person upon the exercise of stock options."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the $1.00 exercise price per share of the stock options exercised, which was paid by the Reporting Person upon exercise of such stock options."}],"balance_after":246226,"source":{"system":"sec-edgar","filing":"0001104659-23-004999","document":"tm233905-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1558569/000110465923004999/tm233905-2_4seq1.xml","form_type":"4"}},{"id":2050458,"issuer":{"id":8372,"kind":"organization","name":"iSpecimen Inc."},"owners":[{"id":113386,"kind":"person","name":"Mullan Jill","position":1,"cik":"0001857039","reported_name":"Mullan Jill","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option","published_at":"2023-01-19T21:02:39.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":10000,"price":1.41,"value":14100.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents stock options granted to the reporting person on January 3, 2023, pursuant to the Issuer's Amended and Restated 2021 Stock Incentive Plan. The stock options vest with respect to 2,500 shares on each of March 31, 2023, June 30, 2023, September 30, 2023 and December 31, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Represents remaining granted stock options across all grants."}],"balance_after":76637,"derivative":{"exercise_price":1.41,"expiration_date":"2033-01-03","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001104659-23-004998","document":"tm233905-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1558569/000110465923004998/tm233905-1_4seq1.xml","form_type":"4"}},{"id":2054445,"issuer":{"id":8372,"kind":"organization","name":"iSpecimen Inc."},"owners":[{"id":90806,"kind":"person","name":"Gullans Steven R. Ph.D.","position":1,"cik":"0001571997","reported_name":"Gullans Steven R. Ph.D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option","published_at":"2023-01-13T18:00:33.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":10000,"price":1.41,"value":14100.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents stock options granted to the reporting person on January 3, 2023, pursuant to the Issuer's Amended and Restated Stock Incentive Plan. The stock options vest respect to 2,500 shares on each of March 31, 2023, June 30, 2023, September 30, 2023 and December 31, 2023."}],"balance_after":23525,"derivative":{"exercise_price":1.41,"expiration_date":"2033-01-03","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001104659-23-003747","document":"tm233286-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1558569/000110465923003747/tm233286-5_4seq1.xml","form_type":"4"}},{"id":2054444,"issuer":{"id":8372,"kind":"organization","name":"iSpecimen Inc."},"owners":[{"id":113385,"kind":"person","name":"Basile Joseph J.","position":1,"cik":"0001954843","reported_name":"Basile Joseph J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option","published_at":"2023-01-13T18:00:08.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":10000,"price":1.41,"value":14100.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents stock options granted to the reporting person on January 3, 2023, pursuant to the Issuer's Amended and Restated Stock Incentive Plan. The stock options vest respect to 2,500 shares on each of March 31, 2023, June 30, 2023, September 30, 2023 and December 31, 2023."}],"balance_after":11668,"derivative":{"exercise_price":1.41,"expiration_date":"2033-01-03","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001104659-23-003746","document":"tm233286-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1558569/000110465923003746/tm233286-4_4seq1.xml","form_type":"4"}},{"id":2054446,"issuer":{"id":8372,"kind":"organization","name":"iSpecimen Inc."},"owners":[{"id":117036,"kind":"person","name":"Scholl George H.","position":1,"cik":"0001857026","reported_name":"Scholl George H.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option","published_at":"2023-01-13T17:59:21.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":10000,"price":1.41,"value":14100.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents stock options granted to the reporting person on January 3, 2023, pursuant to the Issuer's Amended and Restated Stock Incentive Plan. The stock options vest respect to 2,500 shares on each of March 31, 2023, June 30, 2023, September 30, 2023 and December 31, 2023."}],"balance_after":23525,"derivative":{"exercise_price":1.41,"expiration_date":"2033-01-03","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001104659-23-003744","document":"tm233286-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1558569/000110465923003744/tm233286-2_4seq1.xml","form_type":"4"}},{"id":2054443,"issuer":{"id":8372,"kind":"organization","name":"iSpecimen Inc."},"owners":[{"id":90805,"kind":"person","name":"Ross Andrew L.","position":1,"cik":"0001857013","reported_name":"Ross Andrew L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option","published_at":"2023-01-13T17:58:54.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":10000,"price":1.41,"value":14100.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents stock options granted to the reporting person on January 3, 2023, pursuant to the Issuer's Amended and Restated Stock Incentive Plan. The stock options vest respect to 2,500 shares on each of March 31, 2023, June 30, 2023, September 30, 2023 and December 31, 2023."}],"balance_after":23525,"derivative":{"exercise_price":1.41,"expiration_date":"2033-01-03","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001104659-23-003742","document":"tm233286-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1558569/000110465923003742/tm233286-1_4seq1.xml","form_type":"4"}},{"id":2054555,"issuer":{"id":8372,"kind":"organization","name":"iSpecimen Inc."},"owners":[{"id":90814,"kind":"person","name":"Brooks John L. III","position":1,"cik":"0001343930","reported_name":"Brooks John L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option","published_at":"2023-01-13T12:59:41.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":10000,"price":1.41,"value":14100.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents stock options granted to the reporting person on January 3, 2023, pursuant to the Issuer's Amended and Restated Stock Incentive Plan. The stock options vest respect to 2,500 shares on each of March 31, 2023, June 30, 2023, September 30, 2023 and December 31, 2023."}],"balance_after":23525,"derivative":{"exercise_price":1.41,"expiration_date":"2033-01-03","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001104659-23-003745","document":"tm233286-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1343930/000110465923003745/tm233286-3_4seq1.xml","form_type":"4"}},{"id":2117496,"issuer":{"id":8372,"kind":"organization","name":"iSpecimen Inc."},"owners":[{"id":113384,"kind":"person","name":"Ianelli Christopher","position":1,"cik":"0001857027","reported_name":"Ianelli Christopher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option","published_at":"2022-11-14T13:02:03.000Z","date":"2022-10-24","kind":"other","acquired":false,"shares":564,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Represents unvested stock options that were forfeited upon the termination of employment of the reporting person with the issuer. Stock options exercisable for an aggregate of 845 shares that were vested on the date of termination of employment of the reporting person will expire on January 22, 2023, if not exercised by the reporting person before that date."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents unvested stock options that were forfeited upon the termination of employment of the reporting person with the issuer. Stock options exercisable for an aggregate of 845 shares that were vested on the date of termination of employment of the reporting person will expire on January 22, 2023, if not exercised by the reporting person before that date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents unvested stock options that were forfeited upon the termination of employment of the reporting person with the issuer. Stock options exercisable for an aggregate of 845 shares that were vested on the date of termination of employment of the reporting person will expire on January 22, 2023, if not exercised by the reporting person before that date."}],"balance_after":845,"derivative":{"expiration_date":"2022-10-24","underlying":"Common Stock","underlying_shares":564},"source":{"system":"sec-edgar","filing":"0001104659-22-117765","document":"tm2230264-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1558569/000110465922117765/tm2230264-2_4seq1.xml","form_type":"4"}},{"id":2117495,"issuer":{"id":8372,"kind":"organization","name":"iSpecimen Inc."},"owners":[{"id":113384,"kind":"person","name":"Ianelli Christopher","position":1,"cik":"0001857027","reported_name":"Ianelli Christopher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-11-14T13:02:03.000Z","date":"2022-10-24","kind":"other","acquired":false,"shares":18229,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Pursuant to certain separation agreement, dated October 24, 2022, by and between the issuer and the reporting person, (i) an aggregate of 13,021 restricted stock units of the issuer (the \"RSUs\"), which were previously awarded to the reporting person but not settled, were settled at an accelerated vesting schedule and as a result, 13,021 shares of common stock were issued to the reporting person; and (ii) 18,229 RSUs, which were previously awarded to the reporting person and not settled, were forfeited."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to certain separation agreement, dated October 24, 2022, by and between the issuer and the reporting person, (i) an aggregate of 13,021 restricted stock units of the issuer (the \"RSUs\"), which were previously awarded to the reporting person but not settled, were settled at an accelerated vesting schedule and as a result, 13,021 shares of common stock were issued to the reporting person; and (ii) 18,229 RSUs, which were previously awarded to the reporting person and not settled, were forfeited."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The RSUs were previously awarded as compensation to the reporting person for his former service as an officer of the issuer."}],"balance_after":424514,"source":{"system":"sec-edgar","filing":"0001104659-22-117765","document":"tm2230264-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1558569/000110465922117765/tm2230264-2_4seq1.xml","form_type":"4"}},{"id":2119777,"issuer":{"id":8372,"kind":"organization","name":"iSpecimen Inc."},"owners":[{"id":113386,"kind":"person","name":"Mullan Jill","position":1,"cik":"0001857039","reported_name":"Mullan Jill","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option","published_at":"2022-11-10T21:10:33.000Z","date":"2022-10-24","kind":"other","acquired":false,"shares":564,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Represents unvested stock options that were forfeited upon the termination of employment of the reporting person with the issuer. Stock options exercisable for an aggregate of 66,637 shares that were vested on the date of termination of employment of the reporting person will expire on January 22, 2023, if not exercised by the reporting person before that date."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents unvested stock options that were forfeited upon the termination of employment of the reporting person with the issuer. Stock options exercisable for an aggregate of 66,637 shares that were vested on the date of termination of employment of the reporting person will expire on January 22, 2023, if not exercised by the reporting person before that date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents unvested stock options that were forfeited upon the termination of employment of the reporting person with the issuer. Stock options exercisable for an aggregate of 66,637 shares that were vested on the date of termination of employment of the reporting person will expire on January 22, 2023, if not exercised by the reporting person before that date."}],"balance_after":66637,"derivative":{"expiration_date":"2022-10-24","underlying":"Common Stock","underlying_shares":564},"source":{"system":"sec-edgar","filing":"0001104659-22-117133","document":"tm2230264-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1558569/000110465922117133/tm2230264-1_4seq1.xml","form_type":"4"}},{"id":2119776,"issuer":{"id":8372,"kind":"organization","name":"iSpecimen Inc."},"owners":[{"id":113386,"kind":"person","name":"Mullan Jill","position":1,"cik":"0001857039","reported_name":"Mullan Jill","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-11-10T21:10:33.000Z","date":"2022-10-24","kind":"other","acquired":false,"shares":18229,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Pursuant to certain separation agreement, dated October 24, 2022 (the \"Separation Agreement\"), by and between the issuer and the reporting person, (i) an aggregate of 13,021 restricted stock units of the issuer (the \"RSUs\"), which were previously awarded to the reporting person but not settled, were settled at an accelerated vesting schedule and as a result, 13,021 shares of common stock were issued to the reporting person; and (ii) 18,229 RSUs, which were previously awarded to the reporting person and not settled, were forfeited."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to certain separation agreement, dated October 24, 2022 (the \"Separation Agreement\"), by and between the issuer and the reporting person, (i) an aggregate of 13,021 restricted stock units of the issuer (the \"RSUs\"), which were previously awarded to the reporting person but not settled, were settled at an accelerated vesting schedule and as a result, 13,021 shares of common stock were issued to the reporting person; and (ii) 18,229 RSUs, which were previously awarded to the reporting person and not settled, were forfeited."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The RSUs were previously awarded as compensation to the reporting person for her former service as an officer of the issuer."}],"balance_after":179589,"source":{"system":"sec-edgar","filing":"0001104659-22-117133","document":"tm2230264-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1558569/000110465922117133/tm2230264-1_4seq1.xml","form_type":"4"}},{"id":2124175,"issuer":{"id":8372,"kind":"organization","name":"iSpecimen Inc."},"owners":[{"id":112896,"kind":"person","name":"Curley Tracy","position":1,"cik":"0001857028","reported_name":"Curley Tracy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO, CFO and Treasurer"}}],"security":"Option","published_at":"2022-11-04T21:27:39.000Z","date":"2022-11-01","kind":"grant","acquired":true,"shares":100000,"price":1.61,"value":161000.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents 91,235 and 8,765 options granted on November 1, 2022 under the Issuer's 2013 Stock Incentive Plan and the 2021 Stock Incentive Plan, respectively, 25% of which were subject to a one-year cliff with the remaining 75% vested/to be vested quarterly over three years. The vesting commence date is October 24, 2022. The stock options were awarded as compensation to the Reporting Person for her service as an officer of the Company."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents 91,235 and 8,765 options granted on November 1, 2022 under the Issuer's 2013 Stock Incentive Plan and the 2021 Stock Incentive Plan, respectively, 25% of which were subject to a one-year cliff with the remaining 75% vested/to be vested quarterly over three years. The vesting commence date is October 24, 2022. The stock options were awarded as compensation to the Reporting Person for her service as an officer of the Company."}],"balance_after":100000,"derivative":{"expiration_date":"2032-11-01","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001104659-22-114982","document":"tm2229745-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1558569/000110465922114982/tm2229745-2_4seq1.xml","form_type":"4"}},{"id":2124172,"issuer":{"id":8372,"kind":"organization","name":"iSpecimen Inc."},"owners":[{"id":109667,"kind":"person","name":"Bielak Benjamin","position":1,"cik":"0001857054","reported_name":"Bielak Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Information Officer"}}],"security":"Option","published_at":"2022-11-04T21:26:01.000Z","date":"2022-11-01","kind":"grant","acquired":true,"shares":30000,"price":1.61,"value":48300.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents stock options granted on November 1, 2022 under the Issuer's 2013 Stock Incentive Plan, 25% of which were subject to a one-year cliff with the remaining 75% vested/to be vested quarterly over three years. The vesting commence date is June 21, 2022. The stock options were awarded as compensation to the Reporting Person for his service as an officer of the Company."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents stock options granted on November 1, 2022 under the Issuer's 2013 Stock Incentive Plan, 25% of which were subject to a one-year cliff with the remaining 75% vested/to be vested quarterly over three years. The vesting commence date is June 21, 2022. The stock options were awarded as compensation to the Reporting Person for his service as an officer of the Company."}],"balance_after":57952,"derivative":{"expiration_date":"2032-11-01","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001104659-22-114980","document":"tm2229745-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1558569/000110465922114980/tm2229745-1_4seq1.xml","form_type":"4"}},{"id":2221825,"issuer":{"id":8372,"kind":"organization","name":"iSpecimen Inc."},"owners":[{"id":112896,"kind":"person","name":"Curley Tracy","position":1,"cik":"0001857028","reported_name":"Curley Tracy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Treasurer"}}],"security":"Common Stock","published_at":"2022-06-24T21:14:14.000Z","date":"2022-06-22","kind":"tax_withholding","acquired":false,"shares":2738,"price":2.36,"value":6461.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold and the proceeds were paid to the Issuer to satisfy tax withholding obligations."}],"balance_after":45141,"source":{"system":"sec-edgar","filing":"0001104659-22-074371","document":"tm2219397-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1558569/000110465922074371/tm2219397-4_4seq1.xml","form_type":"4"}},{"id":2221823,"issuer":{"id":8372,"kind":"organization","name":"iSpecimen Inc."},"owners":[{"id":113386,"kind":"person","name":"Mullan Jill","position":1,"cik":"0001857039","reported_name":"Mullan Jill","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO and Secretary"}}],"security":"Common Stock","published_at":"2022-06-24T21:13:19.000Z","date":"2022-06-22","kind":"tax_withholding","acquired":false,"shares":3124,"price":2.36,"value":7372.64,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold and the proceeds were paid to the Issuer to satisfy tax withholding obligations."}],"balance_after":197818,"source":{"system":"sec-edgar","filing":"0001104659-22-074370","document":"tm2219397-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1558569/000110465922074370/tm2219397-3_4seq1.xml","form_type":"4"}},{"id":2221824,"issuer":{"id":8372,"kind":"organization","name":"iSpecimen Inc."},"owners":[{"id":113384,"kind":"person","name":"Ianelli Christopher","position":1,"cik":"0001857027","reported_name":"Ianelli Christopher","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2022-06-24T21:13:03.000Z","date":"2022-06-22","kind":"tax_withholding","acquired":false,"shares":3903,"price":2.36,"value":9211.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold and the proceeds were paid to the Issuer to satisfy tax withholding obligations."}],"balance_after":442743,"source":{"system":"sec-edgar","filing":"0001104659-22-074368","document":"tm2219397-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1558569/000110465922074368/tm2219397-2_4seq1.xml","form_type":"4"}},{"id":2221822,"issuer":{"id":8372,"kind":"organization","name":"iSpecimen Inc."},"owners":[{"id":109667,"kind":"person","name":"Bielak Benjamin","position":1,"cik":"0001857054","reported_name":"Bielak Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Information Officer"}}],"security":"Common Stock","published_at":"2022-06-24T21:12:28.000Z","date":"2022-06-22","kind":"tax_withholding","acquired":false,"shares":3148,"price":2.36,"value":7429.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold and the proceeds were paid to the Issuer to satisfy tax withholding obligations."}],"balance_after":66348,"source":{"system":"sec-edgar","filing":"0001104659-22-074366","document":"tm2219397-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1558569/000110465922074366/tm2219397-1_4seq1.xml","form_type":"4"}},{"id":2374087,"issuer":{"id":8372,"kind":"organization","name":"iSpecimen Inc."},"owners":[{"id":113384,"kind":"person","name":"Ianelli Christopher","position":1,"cik":"0001857027","reported_name":"Ianelli Christopher","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Option","published_at":"2022-02-24T22:00:45.000Z","date":"2022-02-23","kind":"exercise","acquired":false,"shares":48106,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Represents the stock options granted to the Reporting Person on July 13, 2019, pursuant to the Issuer's 2010 Stock Incentive Plan, which were fully vested on July 14, 2019."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Represents remaining granted stock options across all grants."}],"balance_after":1409,"derivative":{"exercise_price":1,"expiration_date":"2029-07-12","underlying":"Common Stock","underlying_shares":48106},"source":{"system":"sec-edgar","filing":"0001104659-22-026697","document":"tm227646-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1558569/000110465922026697/tm227646-1_4seq1.xml","form_type":"4"}},{"id":2374086,"issuer":{"id":8372,"kind":"organization","name":"iSpecimen Inc."},"owners":[{"id":113384,"kind":"person","name":"Ianelli Christopher","position":1,"cik":"0001857027","reported_name":"Ianelli Christopher","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Option","published_at":"2022-02-24T22:00:45.000Z","date":"2022-02-22","kind":"exercise","acquired":false,"shares":3099,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents a portion of the stock options granted to the Reporting Person on April 26, 2019, pursuant to the Issuer's 2013 Stock Incentive Plan, which were fully vested on November 30, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Represents remaining granted stock options across all grants."}],"balance_after":49515,"derivative":{"exercise_price":1,"expiration_date":"2029-01-31","underlying":"Common Stock","underlying_shares":3099},"source":{"system":"sec-edgar","filing":"0001104659-22-026697","document":"tm227646-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1558569/000110465922026697/tm227646-1_4seq1.xml","form_type":"4"}},{"id":2374085,"issuer":{"id":8372,"kind":"organization","name":"iSpecimen Inc."},"owners":[{"id":113384,"kind":"person","name":"Ianelli Christopher","position":1,"cik":"0001857027","reported_name":"Ianelli Christopher","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2022-02-24T22:00:45.000Z","date":"2022-02-23","kind":"exercise","acquired":true,"shares":48106,"price":1,"value":48106.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Acquisition of shares of common stock by the Reporting Person upon the exercise of stock options."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the $1.00 exercise price per share of the stock options exercised, which was paid by the Reporting Person upon exercise of such stock options."}],"balance_after":446646,"source":{"system":"sec-edgar","filing":"0001104659-22-026697","document":"tm227646-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1558569/000110465922026697/tm227646-1_4seq1.xml","form_type":"4"}},{"id":2374084,"issuer":{"id":8372,"kind":"organization","name":"iSpecimen Inc."},"owners":[{"id":113384,"kind":"person","name":"Ianelli Christopher","position":1,"cik":"0001857027","reported_name":"Ianelli Christopher","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2022-02-24T22:00:45.000Z","date":"2022-02-22","kind":"exercise","acquired":true,"shares":3099,"price":1,"value":3099.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Acquisition of shares of common stock by the Reporting Person upon the exercise of stock options."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the $1.00 exercise price per share of the stock options exercised, which was paid by the Reporting Person upon exercise of such stock options."}],"balance_after":398540,"source":{"system":"sec-edgar","filing":"0001104659-22-026697","document":"tm227646-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1558569/000110465922026697/tm227646-1_4seq1.xml","form_type":"4"}},{"id":2377494,"issuer":{"id":8372,"kind":"organization","name":"iSpecimen Inc."},"owners":[{"id":113386,"kind":"person","name":"Mullan Jill","position":1,"cik":"0001857039","reported_name":"Mullan Jill","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & Secretary"}}],"security":"Option","published_at":"2022-02-23T22:20:03.000Z","date":"2022-02-22","kind":"exercise","acquired":false,"shares":3099,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Represents a portion of the stock options granted to the Reporting Person on February 1, 2019, pursuant to the Issuer's 2013 Stock Incentive Plan, which were fully vested on February 1, 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Represents remaining granted stock options across all grants."}],"balance_after":67201,"derivative":{"exercise_price":1,"expiration_date":"2029-01-31","underlying":"Common Stock","underlying_shares":3099},"source":{"system":"sec-edgar","filing":"0001104659-22-026191","document":"tm227509-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1558569/000110465922026191/tm227509-1_4seq1.xml","form_type":"4"}},{"id":2377493,"issuer":{"id":8372,"kind":"organization","name":"iSpecimen Inc."},"owners":[{"id":113386,"kind":"person","name":"Mullan Jill","position":1,"cik":"0001857039","reported_name":"Mullan Jill","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & Secretary"}}],"security":"Option","published_at":"2022-02-23T22:20:03.000Z","date":"2022-02-22","kind":"exercise","acquired":false,"shares":19296,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents a portion of the stock options granted to the Reporting Person on June 30, 2016, pursuant to the Issuer's 2013 Stock Incentive Plan, which were fully vested on June 30, 2019."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Represents remaining granted stock options across all grants."}],"balance_after":70300,"derivative":{"exercise_price":1,"expiration_date":"2026-06-29","underlying":"Common Stock","underlying_shares":19296},"source":{"system":"sec-edgar","filing":"0001104659-22-026191","document":"tm227509-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1558569/000110465922026191/tm227509-1_4seq1.xml","form_type":"4"}},{"id":2377492,"issuer":{"id":8372,"kind":"organization","name":"iSpecimen Inc."},"owners":[{"id":113386,"kind":"person","name":"Mullan Jill","position":1,"cik":"0001857039","reported_name":"Mullan Jill","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & Secretary"}}],"security":"Common Stock","published_at":"2022-02-23T22:20:03.000Z","date":"2022-02-22","kind":"exercise","acquired":true,"shares":3099,"price":1,"value":3099.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Acquisition of shares of common stock by the Reporting Person upon the exercise of stock options."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the $1.00 exercise price per share of the stock options exercised, which was paid by the Reporting Person upon exercise of such stock options."}],"balance_after":200942,"source":{"system":"sec-edgar","filing":"0001104659-22-026191","document":"tm227509-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1558569/000110465922026191/tm227509-1_4seq1.xml","form_type":"4"}},{"id":2377491,"issuer":{"id":8372,"kind":"organization","name":"iSpecimen Inc."},"owners":[{"id":113386,"kind":"person","name":"Mullan Jill","position":1,"cik":"0001857039","reported_name":"Mullan Jill","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & Secretary"}}],"security":"Common Stock","published_at":"2022-02-23T22:20:03.000Z","date":"2022-02-22","kind":"exercise","acquired":true,"shares":19296,"price":1,"value":19296.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Acquisition of shares of common stock by the Reporting Person upon the exercise of stock options."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the $1.00 exercise price per share of the stock options exercised, which was paid by the Reporting Person upon exercise of such stock options."}],"balance_after":197843,"source":{"system":"sec-edgar","filing":"0001104659-22-026191","document":"tm227509-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1558569/000110465922026191/tm227509-1_4seq1.xml","form_type":"4"}},{"id":2397186,"issuer":{"id":8372,"kind":"organization","name":"iSpecimen Inc."},"owners":[{"id":117036,"kind":"person","name":"Scholl George H.","position":1,"cik":"0001857026","reported_name":"Scholl George H.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Options","published_at":"2022-02-14T20:32:07.000Z","date":"2021-07-30","kind":"grant","acquired":true,"shares":13525,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Each non-qualified stock option (\"NSO\") represents a contingent right to exercise for one share of common stock upon vesting subject to the terms and conditions set forth in the award of such NSOs by iSpecimen Inc. (the \"Company\") to the Reporting Person pursuant to a Nonqualified Stock Option Award Agreement (the \"NSO Agreement\") under the iSpecimen Inc. 2021 Amended and Restated Stock Incentive Plan, as amended. The NSOs has a vesting term of three years with a one- year cliff (i.e. 33.33% of the NSOs vest on June 21, 2022, and the rest of the NSOs vest in equal quarterly installments on September 21, 2022 and each December 21, March 21, June 21 and September 21 until June 21, 2024), subject to the terms and conditions set forth in the NSO Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The NSOs were awarded as compensation to the Reporting Person for his service as a director of the Company."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each non-qualified stock option (\"NSO\") represents a contingent right to exercise for one share of common stock upon vesting subject to the terms and conditions set forth in the award of such NSOs by iSpecimen Inc. (the \"Company\") to the Reporting Person pursuant to a Nonqualified Stock Option Award Agreement (the \"NSO Agreement\") under the iSpecimen Inc. 2021 Amended and Restated Stock Incentive Plan, as amended. The NSOs has a vesting term of three years with a one- year cliff (i.e. 33.33% of the NSOs vest on June 21, 2022, and the rest of the NSOs vest in equal quarterly installments on September 21, 2022 and each December 21, March 21, June 21 and September 21 until June 21, 2024), subject to the terms and conditions set forth in the NSO Agreement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each non-qualified stock option (\"NSO\") represents a contingent right to exercise for one share of common stock upon vesting subject to the terms and conditions set forth in the award of such NSOs by iSpecimen Inc. (the \"Company\") to the Reporting Person pursuant to a Nonqualified Stock Option Award Agreement (the \"NSO Agreement\") under the iSpecimen Inc. 2021 Amended and Restated Stock Incentive Plan, as amended. The NSOs has a vesting term of three years with a one- year cliff (i.e. 33.33% of the NSOs vest on June 21, 2022, and the rest of the NSOs vest in equal quarterly installments on September 21, 2022 and each December 21, March 21, June 21 and September 21 until June 21, 2024), subject to the terms and conditions set forth in the NSO Agreement."}],"balance_after":13525,"derivative":{"exercise_price":8,"underlying":"Common Stock","underlying_shares":13525},"source":{"system":"sec-edgar","filing":"0001104659-22-022576","document":"tm226491-8_5seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1558569/000110465922022576/tm226491-8_5seq1.xml","form_type":"5"}},{"id":2397185,"issuer":{"id":8372,"kind":"organization","name":"iSpecimen Inc."},"owners":[{"id":117036,"kind":"person","name":"Scholl George H.","position":1,"cik":"0001857026","reported_name":"Scholl George H.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-02-14T20:32:07.000Z","date":"2021-07-30","kind":"grant","acquired":true,"shares":2500,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each share of common stock was awarded as a restricted stock unit (\"RSU\"), each of which is a contingent right to receive one share of common stock at settlement subject to the terms and conditions set forth in the award of such RSUs by the Company to the Reporting Person pursuant to a Restricted Stock Unit Award Agreement (the \"RSU Agreement\"). The RSUs vest in four equal quarterly installments on September 21, 2021, December 21, 2021, March 21, 2022 and June 21, 2022, subject to the terms and conditions set forth in the RSU Agreement. 625 RSUs and 625 RSUs were settled for shares of common stock on September 30, 2021 and December 31, 2021, respectively, and the Reporting Person was issued 1,250 shares of common stock."},{"field":"shares","element":"transactionShares","label":"F1","text":"Each share of common stock was awarded as a restricted stock unit (\"RSU\"), each of which is a contingent right to receive one share of common stock at settlement subject to the terms and conditions set forth in the award of such RSUs by the Company to the Reporting Person pursuant to a Restricted Stock Unit Award Agreement (the \"RSU Agreement\"). The RSUs vest in four equal quarterly installments on September 21, 2021, December 21, 2021, March 21, 2022 and June 21, 2022, subject to the terms and conditions set forth in the RSU Agreement. 625 RSUs and 625 RSUs were settled for shares of common stock on September 30, 2021 and December 31, 2021, respectively, and the Reporting Person was issued 1,250 shares of common stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The RSUs were awarded as compensation to the Reporting Person for his service as the director of the Company."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Each share of common stock was awarded as a restricted stock unit (\"RSU\"), each of which is a contingent right to receive one share of common stock at settlement subject to the terms and conditions set forth in the award of such RSUs by the Company to the Reporting Person pursuant to a Restricted Stock Unit Award Agreement (the \"RSU Agreement\"). The RSUs vest in four equal quarterly installments on September 21, 2021, December 21, 2021, March 21, 2022 and June 21, 2022, subject to the terms and conditions set forth in the RSU Agreement. 625 RSUs and 625 RSUs were settled for shares of common stock on September 30, 2021 and December 31, 2021, respectively, and the Reporting Person was issued 1,250 shares of common stock."}],"balance_after":2500,"source":{"system":"sec-edgar","filing":"0001104659-22-022576","document":"tm226491-8_5seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1558569/000110465922022576/tm226491-8_5seq1.xml","form_type":"5"}},{"id":2397178,"issuer":{"id":8372,"kind":"organization","name":"iSpecimen Inc."},"owners":[{"id":117037,"kind":"person","name":"Lawrence Margaret H.","position":1,"cik":"0001857015","reported_name":"Lawrence Margaret H.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Options","published_at":"2022-02-14T20:31:08.000Z","date":"2021-07-30","kind":"grant","acquired":true,"shares":13525,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Each non-qualified stock option (\"NSO\") represents a contingent right to receive one share of common stock upon exercise subject to the terms and conditions set forth in the award of such NSOs by iSpecimen Inc. (the \"Company\") to the Reporting Person pursuant to a Nonqualified Stock Option Award Agreement (the \"NSO Agreement\") under the iSpecimen Inc. 2021 Amended and Restated Stock Incentive Plan, as amended. The NSOs has a vesting term of three years with a one-year cliff (i.e. 33.33% of the NSOs vest on June 21, 2022, and the rest of the NSOs vest in equal quarterly installments on September 21, 2022 and each December 21, March 21, June 21 and September 21 until June 21, 2024), subject to the terms and conditions set forth in the NSO Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The NSOs were awarded as compensation to the Reporting Person for her service as a director of the Company."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each non-qualified stock option (\"NSO\") represents a contingent right to receive one share of common stock upon exercise subject to the terms and conditions set forth in the award of such NSOs by iSpecimen Inc. (the \"Company\") to the Reporting Person pursuant to a Nonqualified Stock Option Award Agreement (the \"NSO Agreement\") under the iSpecimen Inc. 2021 Amended and Restated Stock Incentive Plan, as amended. The NSOs has a vesting term of three years with a one-year cliff (i.e. 33.33% of the NSOs vest on June 21, 2022, and the rest of the NSOs vest in equal quarterly installments on September 21, 2022 and each December 21, March 21, June 21 and September 21 until June 21, 2024), subject to the terms and conditions set forth in the NSO Agreement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each non-qualified stock option (\"NSO\") represents a contingent right to receive one share of common stock upon exercise subject to the terms and conditions set forth in the award of such NSOs by iSpecimen Inc. (the \"Company\") to the Reporting Person pursuant to a Nonqualified Stock Option Award Agreement (the \"NSO Agreement\") under the iSpecimen Inc. 2021 Amended and Restated Stock Incentive Plan, as amended. The NSOs has a vesting term of three years with a one-year cliff (i.e. 33.33% of the NSOs vest on June 21, 2022, and the rest of the NSOs vest in equal quarterly installments on September 21, 2022 and each December 21, March 21, June 21 and September 21 until June 21, 2024), subject to the terms and conditions set forth in the NSO Agreement."}],"balance_after":13525,"derivative":{"exercise_price":8,"underlying":"Common Stock","underlying_shares":13525},"source":{"system":"sec-edgar","filing":"0001104659-22-022572","document":"tm226491-7_5seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1558569/000110465922022572/tm226491-7_5seq1.xml","form_type":"5"}},{"id":2397177,"issuer":{"id":8372,"kind":"organization","name":"iSpecimen Inc."},"owners":[{"id":117037,"kind":"person","name":"Lawrence Margaret H.","position":1,"cik":"0001857015","reported_name":"Lawrence Margaret H.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-02-14T20:31:08.000Z","date":"2021-07-30","kind":"grant","acquired":true,"shares":2500,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares underlying certain restricted stock units (\"RSUs\") each of which represents a contingent right to receive one share of common stock at settlement subject to the terms and conditions set forth in the award of such RSUs by the Company to the Reporting Person pursuant to a Restricted Stock Unit Award Agreement (the \"RSU Agreement\"). The RSUs vest in four equal quarterly installments on September 21, 2021, December 21, 2021, March 21, 2022 and June 21, 2022, subject to the terms and conditions set forth in the RSU Agreement. 625 RSUs and 625 RSUs were settled for shares of common stock on June 30, 2021 and December 31, 2021, respectively, and the Reporting Person was issued 1,250 shares of common stock."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying certain restricted stock units (\"RSUs\") each of which represents a contingent right to receive one share of common stock at settlement subject to the terms and conditions set forth in the award of such RSUs by the Company to the Reporting Person pursuant to a Restricted Stock Unit Award Agreement (the \"RSU Agreement\"). The RSUs vest in four equal quarterly installments on September 21, 2021, December 21, 2021, March 21, 2022 and June 21, 2022, subject to the terms and conditions set forth in the RSU Agreement. 625 RSUs and 625 RSUs were settled for shares of common stock on June 30, 2021 and December 31, 2021, respectively, and the Reporting Person was issued 1,250 shares of common stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The RSUs were awarded as compensation to the Reporting Person for her service as the director of the Company."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Represents shares underlying certain restricted stock units (\"RSUs\") each of which represents a contingent right to receive one share of common stock at settlement subject to the terms and conditions set forth in the award of such RSUs by the Company to the Reporting Person pursuant to a Restricted Stock Unit Award Agreement (the \"RSU Agreement\"). The RSUs vest in four equal quarterly installments on September 21, 2021, December 21, 2021, March 21, 2022 and June 21, 2022, subject to the terms and conditions set forth in the RSU Agreement. 625 RSUs and 625 RSUs were settled for shares of common stock on June 30, 2021 and December 31, 2021, respectively, and the Reporting Person was issued 1,250 shares of common stock."}],"balance_after":2500,"source":{"system":"sec-edgar","filing":"0001104659-22-022572","document":"tm226491-7_5seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1558569/000110465922022572/tm226491-7_5seq1.xml","form_type":"5"}},{"id":2397181,"issuer":{"id":8372,"kind":"organization","name":"iSpecimen Inc."},"owners":[{"id":90806,"kind":"person","name":"Gullans Steven R. Ph.D.","position":1,"cik":"0001571997","reported_name":"Gullans Steven R. Ph.D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Options","published_at":"2022-02-14T20:30:32.000Z","date":"2021-07-30","kind":"grant","acquired":true,"shares":13525,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Each non-qualified stock option (\"NSO\") represents a contingent right to receive one share of common stock upon exercise subject to the terms and conditions set forth in the award of such NSOs by iSpecimen Inc. (the \"Company\") to the Reporting Person pursuant to a Nonqualified Stock Option Award Agreement (the \"NSO Agreement\") under the iSpecimen Inc. 2021 Amended and Restated Stock Incentive Plan, as amended. The NSOs has a vesting term of three years with a one-year cliff (i.e. 33.33% of the NSOs vest on June 21, 2022, and the rest of the NSOs vest in equal quarterly installments on September 21, 2022 and each December 21, March 21, June 21 and September 21 until June 21, 2024), subject to the terms and conditions set forth in the NSO Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The NSOs were awarded as compensation to the Reporting Person for his service as a director of the Company."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each non-qualified stock option (\"NSO\") represents a contingent right to receive one share of common stock upon exercise subject to the terms and conditions set forth in the award of such NSOs by iSpecimen Inc. (the \"Company\") to the Reporting Person pursuant to a Nonqualified Stock Option Award Agreement (the \"NSO Agreement\") under the iSpecimen Inc. 2021 Amended and Restated Stock Incentive Plan, as amended. The NSOs has a vesting term of three years with a one-year cliff (i.e. 33.33% of the NSOs vest on June 21, 2022, and the rest of the NSOs vest in equal quarterly installments on September 21, 2022 and each December 21, March 21, June 21 and September 21 until June 21, 2024), subject to the terms and conditions set forth in the NSO Agreement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each non-qualified stock option (\"NSO\") represents a contingent right to receive one share of common stock upon exercise subject to the terms and conditions set forth in the award of such NSOs by iSpecimen Inc. (the \"Company\") to the Reporting Person pursuant to a Nonqualified Stock Option Award Agreement (the \"NSO Agreement\") under the iSpecimen Inc. 2021 Amended and Restated Stock Incentive Plan, as amended. The NSOs has a vesting term of three years with a one-year cliff (i.e. 33.33% of the NSOs vest on June 21, 2022, and the rest of the NSOs vest in equal quarterly installments on September 21, 2022 and each December 21, March 21, June 21 and September 21 until June 21, 2024), subject to the terms and conditions set forth in the NSO Agreement."}],"balance_after":13525,"derivative":{"exercise_price":8,"underlying":"Common Stock","underlying_shares":13525},"source":{"system":"sec-edgar","filing":"0001104659-22-022568","document":"tm226491-6_5seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1558569/000110465922022568/tm226491-6_5seq1.xml","form_type":"5"}},{"id":2397180,"issuer":{"id":8372,"kind":"organization","name":"iSpecimen Inc."},"owners":[{"id":90806,"kind":"person","name":"Gullans Steven R. Ph.D.","position":1,"cik":"0001571997","reported_name":"Gullans Steven R. Ph.D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-02-14T20:30:32.000Z","date":"2021-07-30","kind":"grant","acquired":true,"shares":2500,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares underlying certain restricted stock units (\"RSUs\"), each of which is a contingent right to receive one share of common stock at settlement subject to the terms and conditions set forth in the award of such RSUs by the Company to the Reporting Person pursuant to a Restricted Stock Unit Award Agreement (the \"RSU Agreement\"). The RSUs vest in four equal installments on September 21, 2021, December 21, 2021, March 21, 2022 and June 21, 2022, subject to the terms and conditions set forth in the RSU Agreement. 625 RSUs and 625 RSUs were settled for shares of common stock on September 30, 2021 and December 31, 2021, respectively, and the Reporting Person was issued 1,250 shares of common stock."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying certain restricted stock units (\"RSUs\"), each of which is a contingent right to receive one share of common stock at settlement subject to the terms and conditions set forth in the award of such RSUs by the Company to the Reporting Person pursuant to a Restricted Stock Unit Award Agreement (the \"RSU Agreement\"). The RSUs vest in four equal installments on September 21, 2021, December 21, 2021, March 21, 2022 and June 21, 2022, subject to the terms and conditions set forth in the RSU Agreement. 625 RSUs and 625 RSUs were settled for shares of common stock on September 30, 2021 and December 31, 2021, respectively, and the Reporting Person was issued 1,250 shares of common stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The RSUs were awarded as compensation to the Reporting Person for his service as the director of the Company."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Represents shares underlying certain restricted stock units (\"RSUs\"), each of which is a contingent right to receive one share of common stock at settlement subject to the terms and conditions set forth in the award of such RSUs by the Company to the Reporting Person pursuant to a Restricted Stock Unit Award Agreement (the \"RSU Agreement\"). The RSUs vest in four equal installments on September 21, 2021, December 21, 2021, March 21, 2022 and June 21, 2022, subject to the terms and conditions set forth in the RSU Agreement. 625 RSUs and 625 RSUs were settled for shares of common stock on September 30, 2021 and December 31, 2021, respectively, and the Reporting Person was issued 1,250 shares of common stock."}],"balance_after":2500,"source":{"system":"sec-edgar","filing":"0001104659-22-022568","document":"tm226491-6_5seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1558569/000110465922022568/tm226491-6_5seq1.xml","form_type":"5"}},{"id":2397176,"issuer":{"id":8372,"kind":"organization","name":"iSpecimen Inc."},"owners":[{"id":113386,"kind":"person","name":"Mullan Jill","position":1,"cik":"0001857039","reported_name":"Mullan Jill","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & Secretary"}}],"security":"Common Stock","published_at":"2022-02-14T20:29:36.000Z","date":"2021-07-30","kind":"grant","acquired":true,"shares":52084,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares underlying certain restricted stock units (\"RSUs\"), each of which is a contingent right to receive one share of common stock at settlement subject to the terms and conditions set forth in the award of such RSUs by the Company to the Reporting Person pursuant to a Restricted Stock Unit Award Agreement (the \"RSU Agreement\"). The RSUs vest in five equal installments, on June 21, 2021, June 21, 2022, June 21, 2023, June 21, 2024 and June 21, 2025, subject to the terms and conditions set forth in the RSU Agreement. 10,416 RSUs were settled for shares of common stock on June 21, 2021, and the Reporting Person was issued 10,416 shares of common stock."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying certain restricted stock units (\"RSUs\"), each of which is a contingent right to receive one share of common stock at settlement subject to the terms and conditions set forth in the award of such RSUs by the Company to the Reporting Person pursuant to a Restricted Stock Unit Award Agreement (the \"RSU Agreement\"). The RSUs vest in five equal installments, on June 21, 2021, June 21, 2022, June 21, 2023, June 21, 2024 and June 21, 2025, subject to the terms and conditions set forth in the RSU Agreement. 10,416 RSUs were settled for shares of common stock on June 21, 2021, and the Reporting Person was issued 10,416 shares of common stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The RSUs were awarded as compensation to the Reporting Person for her service as an officer of the Company."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Represents shares underlying certain restricted stock units (\"RSUs\"), each of which is a contingent right to receive one share of common stock at settlement subject to the terms and conditions set forth in the award of such RSUs by the Company to the Reporting Person pursuant to a Restricted Stock Unit Award Agreement (the \"RSU Agreement\"). The RSUs vest in five equal installments, on June 21, 2021, June 21, 2022, June 21, 2023, June 21, 2024 and June 21, 2025, subject to the terms and conditions set forth in the RSU Agreement. 10,416 RSUs were settled for shares of common stock on June 21, 2021, and the Reporting Person was issued 10,416 shares of common stock."}],"balance_after":178547,"source":{"system":"sec-edgar","filing":"0001104659-22-022565","document":"tm226491-5_5seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1558569/000110465922022565/tm226491-5_5seq1.xml","form_type":"5"}},{"id":2397179,"issuer":{"id":8372,"kind":"organization","name":"iSpecimen Inc."},"owners":[{"id":113384,"kind":"person","name":"Ianelli Christopher","position":1,"cik":"0001857027","reported_name":"Ianelli Christopher","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2022-02-14T20:28:49.000Z","date":"2021-07-30","kind":"grant","acquired":true,"shares":52084,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares underlying certain restricted stock units (\"RSUs\"), each of which is a contingent right to receive one share of common stock at settlement subject to the terms and conditions set forth in the award of such RSUs by the Company to the Reporting Person pursuant to a Restricted Stock Unit Award Agreement (the \"RSU Agreement\"). The RSUs vest in five equal installments, on June 21, 2021, June 21, 2022, June 21, 2023, June 21, 2024 and June 21, 2025, subject to the terms and conditions set forth in the RSU Agreement. 10,416 RSUs were settled for shares of common stock on June 21, 2021, and the Reporting Person was issued 10,416 shares of common stock."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying certain restricted stock units (\"RSUs\"), each of which is a contingent right to receive one share of common stock at settlement subject to the terms and conditions set forth in the award of such RSUs by the Company to the Reporting Person pursuant to a Restricted Stock Unit Award Agreement (the \"RSU Agreement\"). The RSUs vest in five equal installments, on June 21, 2021, June 21, 2022, June 21, 2023, June 21, 2024 and June 21, 2025, subject to the terms and conditions set forth in the RSU Agreement. 10,416 RSUs were settled for shares of common stock on June 21, 2021, and the Reporting Person was issued 10,416 shares of common stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The RSUs were awarded as compensation to the Reporting Person for his service as an officer of the Company."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Represents shares underlying certain restricted stock units (\"RSUs\"), each of which is a contingent right to receive one share of common stock at settlement subject to the terms and conditions set forth in the award of such RSUs by the Company to the Reporting Person pursuant to a Restricted Stock Unit Award Agreement (the \"RSU Agreement\"). The RSUs vest in five equal installments, on June 21, 2021, June 21, 2022, June 21, 2023, June 21, 2024 and June 21, 2025, subject to the terms and conditions set forth in the RSU Agreement. 10,416 RSUs were settled for shares of common stock on June 21, 2021, and the Reporting Person was issued 10,416 shares of common stock."}],"balance_after":395441,"source":{"system":"sec-edgar","filing":"0001104659-22-022560","document":"tm226491-4_5seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1558569/000110465922022560/tm226491-4_5seq1.xml","form_type":"5"}},{"id":2397170,"issuer":{"id":8372,"kind":"organization","name":"iSpecimen Inc."},"owners":[{"id":109667,"kind":"person","name":"Bielak Benjamin","position":1,"cik":"0001857054","reported_name":"Bielak Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Information Officer"}}],"security":"Common Stock","published_at":"2022-02-14T20:28:21.000Z","date":"2021-11-30","kind":"other","acquired":true,"shares":282,"price":1,"value":282.0,"ownership":{"direct":true},"balance_after":69496,"source":{"system":"sec-edgar","filing":"0001104659-22-022558","document":"tm226491-3_5seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1558569/000110465922022558/tm226491-3_5seq1.xml","form_type":"5"}},{"id":2397169,"issuer":{"id":8372,"kind":"organization","name":"iSpecimen Inc."},"owners":[{"id":109667,"kind":"person","name":"Bielak Benjamin","position":1,"cik":"0001857054","reported_name":"Bielak Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Information Officer"}}],"security":"Common Stock","published_at":"2022-02-14T20:28:21.000Z","date":"2021-11-29","kind":"other","acquired":true,"shares":1465,"price":1,"value":1465.0,"ownership":{"direct":true},"balance_after":69214,"source":{"system":"sec-edgar","filing":"0001104659-22-022558","document":"tm226491-3_5seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1558569/000110465922022558/tm226491-3_5seq1.xml","form_type":"5"}},{"id":2397168,"issuer":{"id":8372,"kind":"organization","name":"iSpecimen Inc."},"owners":[{"id":109667,"kind":"person","name":"Bielak Benjamin","position":1,"cik":"0001857054","reported_name":"Bielak Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Information Officer"}}],"security":"Common Stock","published_at":"2022-02-14T20:28:21.000Z","date":"2021-09-01","kind":"other","acquired":true,"shares":282,"price":1,"value":282.0,"ownership":{"direct":true},"balance_after":67749,"source":{"system":"sec-edgar","filing":"0001104659-22-022558","document":"tm226491-3_5seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1558569/000110465922022558/tm226491-3_5seq1.xml","form_type":"5"}},{"id":2397167,"issuer":{"id":8372,"kind":"organization","name":"iSpecimen Inc."},"owners":[{"id":109667,"kind":"person","name":"Bielak Benjamin","position":1,"cik":"0001857054","reported_name":"Bielak Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Information Officer"}}],"security":"Common Stock","published_at":"2022-02-14T20:28:21.000Z","date":"2021-07-30","kind":"grant","acquired":true,"shares":47349,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares underlying certain restricted stock units (\"RSUs\"), each of which is a contingent right to receive one share of common stock at settlement subject to the terms and conditions set forth in the award of such RSUs by the Company to the Reporting Person pursuant to a Restricted Stock Unit Award Agreement (the \"RSU Agreement \"). The RSUs vest in five equal installments, on June 21, 2021, June 21, 2022, June21, 2023, June 21, 2024 and June 21,2025, Subject to the terms and conditions set forth in the RSU Agreement. 9,469 RSUs were settled for shares of common stock on June 21, 2021, and the Reporting Person was issued 9,469 shares of common stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The RSUs were awarded as compensation to the Reporting Person for his service as an officer of the Company."}],"balance_after":67467,"source":{"system":"sec-edgar","filing":"0001104659-22-022558","document":"tm226491-3_5seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1558569/000110465922022558/tm226491-3_5seq1.xml","form_type":"5"}},{"id":2397166,"issuer":{"id":8372,"kind":"organization","name":"iSpecimen Inc."},"owners":[{"id":109667,"kind":"person","name":"Bielak Benjamin","position":1,"cik":"0001857054","reported_name":"Bielak Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Information Officer"}}],"security":"Common Stock","published_at":"2022-02-14T20:28:21.000Z","date":"2021-07-02","kind":"other","acquired":true,"shares":1466,"price":1,"value":1466.0,"ownership":{"direct":true},"balance_after":20118,"source":{"system":"sec-edgar","filing":"0001104659-22-022558","document":"tm226491-3_5seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1558569/000110465922022558/tm226491-3_5seq1.xml","form_type":"5"}},{"id":2397165,"issuer":{"id":8372,"kind":"organization","name":"iSpecimen Inc."},"owners":[{"id":109667,"kind":"person","name":"Bielak Benjamin","position":1,"cik":"0001857054","reported_name":"Bielak Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Information Officer"}}],"security":"Common Stock","published_at":"2022-02-14T20:28:21.000Z","date":"2021-06-16","kind":"other","acquired":true,"shares":18652,"price":1,"value":18652.0,"ownership":{"direct":true},"balance_after":18652,"source":{"system":"sec-edgar","filing":"0001104659-22-022558","document":"tm226491-3_5seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1558569/000110465922022558/tm226491-3_5seq1.xml","form_type":"5"}},{"id":2397164,"issuer":{"id":8372,"kind":"organization","name":"iSpecimen Inc."},"owners":[{"id":112896,"kind":"person","name":"Curley Tracy","position":1,"cik":"0001857028","reported_name":"Curley Tracy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Treasurer"}}],"security":"Common Stock","published_at":"2022-02-14T20:25:01.000Z","date":"2021-07-30","kind":"grant","acquired":true,"shares":37879,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares underlying certain restricted stock units (\"RSUs\"), each of which is a contingent right to receive one share of common stock at settlement subject to the terms and conditions set forth in the award of such RSUs by the Company to the Reporting Person pursuant to a Restricted Stock Unit Award Agreement (the \"RSU Agreement\"). The RSUs vest in five equal installments, on June 21, 2021, June 21, 2022, June 21, 2023, June 21, 2024 and June 21, 2025, subject to the terms and conditions set forth in the RSU Agreement. 7,575 RSUs were settled for shares of common stock on June 21, 2021, and the Reporting Person was issued 7,575 shares of common stock."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying certain restricted stock units (\"RSUs\"), each of which is a contingent right to receive one share of common stock at settlement subject to the terms and conditions set forth in the award of such RSUs by the Company to the Reporting Person pursuant to a Restricted Stock Unit Award Agreement (the \"RSU Agreement\"). The RSUs vest in five equal installments, on June 21, 2021, June 21, 2022, June 21, 2023, June 21, 2024 and June 21, 2025, subject to the terms and conditions set forth in the RSU Agreement. 7,575 RSUs were settled for shares of common stock on June 21, 2021, and the Reporting Person was issued 7,575 shares of common stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The RSUs were awarded as compensation to the Reporting Person for her service as an officer of the Company."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Represents shares underlying certain restricted stock units (\"RSUs\"), each of which is a contingent right to receive one share of common stock at settlement subject to the terms and conditions set forth in the award of such RSUs by the Company to the Reporting Person pursuant to a Restricted Stock Unit Award Agreement (the \"RSU Agreement\"). The RSUs vest in five equal installments, on June 21, 2021, June 21, 2022, June 21, 2023, June 21, 2024 and June 21, 2025, subject to the terms and conditions set forth in the RSU Agreement. 7,575 RSUs were settled for shares of common stock on June 21, 2021, and the Reporting Person was issued 7,575 shares of common stock."}],"balance_after":47879,"source":{"system":"sec-edgar","filing":"0001104659-22-022544","document":"tm226491-1_5seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1558569/000110465922022544/tm226491-1_5seq1.xml","form_type":"5"}},{"id":2397402,"issuer":{"id":8372,"kind":"organization","name":"iSpecimen Inc."},"owners":[{"id":90814,"kind":"person","name":"Brooks John L. III","position":1,"cik":"0001343930","reported_name":"Brooks John L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Options","published_at":"2022-02-14T15:27:23.000Z","date":"2021-07-30","kind":"grant","acquired":true,"shares":13525,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Each non-qualified stock option (\"NSO\") represents a contingent right to receive one share of common stock upon exercise subject to the terms and conditions set forth in the award of such NSOs by iSpecimen Inc. (the \"Company\") to the Reporting Person pursuant to a Nonqualified Stock Option Award Agreement (the \"NSO Agreement\") under the iSpecimen Inc. 2021 Amended and Restated Stock Incentive Plan, as amended. The NSOs has a vesting term of three years with a one-year cliff (i.e. 33.33% of the NSOs vest on June 21, 2022, and the rest of the NSOs vest in equal quarterly installments on September 21, 2022 and each December 21, March 21, June 21 and September 21 until June 21, 2024), subject to the terms and conditions set forth in the NSO Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The NSOs were awarded as compensation to the Reporting Person for his service as a director of the Company."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each non-qualified stock option (\"NSO\") represents a contingent right to receive one share of common stock upon exercise subject to the terms and conditions set forth in the award of such NSOs by iSpecimen Inc. (the \"Company\") to the Reporting Person pursuant to a Nonqualified Stock Option Award Agreement (the \"NSO Agreement\") under the iSpecimen Inc. 2021 Amended and Restated Stock Incentive Plan, as amended. The NSOs has a vesting term of three years with a one-year cliff (i.e. 33.33% of the NSOs vest on June 21, 2022, and the rest of the NSOs vest in equal quarterly installments on September 21, 2022 and each December 21, March 21, June 21 and September 21 until June 21, 2024), subject to the terms and conditions set forth in the NSO Agreement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each non-qualified stock option (\"NSO\") represents a contingent right to receive one share of common stock upon exercise subject to the terms and conditions set forth in the award of such NSOs by iSpecimen Inc. (the \"Company\") to the Reporting Person pursuant to a Nonqualified Stock Option Award Agreement (the \"NSO Agreement\") under the iSpecimen Inc. 2021 Amended and Restated Stock Incentive Plan, as amended. The NSOs has a vesting term of three years with a one-year cliff (i.e. 33.33% of the NSOs vest on June 21, 2022, and the rest of the NSOs vest in equal quarterly installments on September 21, 2022 and each December 21, March 21, June 21 and September 21 until June 21, 2024), subject to the terms and conditions set forth in the NSO Agreement."}],"balance_after":13525,"derivative":{"exercise_price":8,"underlying":"Common Stock","underlying_shares":13525},"source":{"system":"sec-edgar","filing":"0001104659-22-022553","document":"tm226491-2_5seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1343930/000110465922022553/tm226491-2_5seq1.xml","form_type":"5"}},{"id":2397401,"issuer":{"id":8372,"kind":"organization","name":"iSpecimen Inc."},"owners":[{"id":90814,"kind":"person","name":"Brooks John L. III","position":1,"cik":"0001343930","reported_name":"Brooks John L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-02-14T15:27:23.000Z","date":"2021-07-30","kind":"grant","acquired":true,"shares":2500,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares underlying certain restricted stock units (\"RSUs\"), each of which represents a contingent right to receive one share of common stock at settlement subject to the terms and conditions set forth in the award of such RSUs by the Company to the Reporting Person pursuant to a Restricted Stock Unit Award Agreement (the \"RSU Agreement\"). The RSUs vest in four equal installments on September 21, 2021, December 21, 2021, March 21, 2022 and June 21, 2022, subject to the terms and conditions set forth in the RSU Agreement. 625 RSUs and 625 RSUs were settled for shares of common stock on June 30, 2021 and December 31, 2021, respectively, and the Reporting Person was issued 1,250 shares of common stock."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying certain restricted stock units (\"RSUs\"), each of which represents a contingent right to receive one share of common stock at settlement subject to the terms and conditions set forth in the award of such RSUs by the Company to the Reporting Person pursuant to a Restricted Stock Unit Award Agreement (the \"RSU Agreement\"). The RSUs vest in four equal installments on September 21, 2021, December 21, 2021, March 21, 2022 and June 21, 2022, subject to the terms and conditions set forth in the RSU Agreement. 625 RSUs and 625 RSUs were settled for shares of common stock on June 30, 2021 and December 31, 2021, respectively, and the Reporting Person was issued 1,250 shares of common stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The RSUs were awarded as compensation to the Reporting Person for his service as the director of the Company."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Represents shares underlying certain restricted stock units (\"RSUs\"), each of which represents a contingent right to receive one share of common stock at settlement subject to the terms and conditions set forth in the award of such RSUs by the Company to the Reporting Person pursuant to a Restricted Stock Unit Award Agreement (the \"RSU Agreement\"). The RSUs vest in four equal installments on September 21, 2021, December 21, 2021, March 21, 2022 and June 21, 2022, subject to the terms and conditions set forth in the RSU Agreement. 625 RSUs and 625 RSUs were settled for shares of common stock on June 30, 2021 and December 31, 2021, respectively, and the Reporting Person was issued 1,250 shares of common stock."}],"balance_after":2500,"source":{"system":"sec-edgar","filing":"0001104659-22-022553","document":"tm226491-2_5seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1343930/000110465922022553/tm226491-2_5seq1.xml","form_type":"5"}},{"id":2492939,"issuer":{"id":8372,"kind":"organization","name":"iSpecimen Inc."},"owners":[{"id":90805,"kind":"person","name":"Ross Andrew L.","position":1,"cik":"0001857013","reported_name":"Ross Andrew L.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Restricted Stock Units","published_at":"2021-11-30T01:01:04.000Z","date":"2021-07-30","kind":"grant","acquired":true,"shares":2500,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of common stock at settlement subject to the terms and conditions set forth in the award of such RSUs by the Company to the Reporting Person pursuant to a Restricted Stock Unit Award Agreement (the \"RSU Agreement\"). The RSUs vest in four equal quarterly installments on September 21, 2021, December 21, 2021, March 21, 2022 and June 21, 2022, subject to the terms and conditions set forth in the RSU Agreement."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of common stock at settlement subject to the terms and conditions set forth in the award of such RSUs by the Company to the Reporting Person pursuant to a Restricted Stock Unit Award Agreement (the \"RSU Agreement\"). The RSUs vest in four equal quarterly installments on September 21, 2021, December 21, 2021, March 21, 2022 and June 21, 2022, subject to the terms and conditions set forth in the RSU Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The derivative securities were awarded as compensation to the Reporting Person for his service as the director of the Company."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of common stock at settlement subject to the terms and conditions set forth in the award of such RSUs by the Company to the Reporting Person pursuant to a Restricted Stock Unit Award Agreement (the \"RSU Agreement\"). The RSUs vest in four equal quarterly installments on September 21, 2021, December 21, 2021, March 21, 2022 and June 21, 2022, subject to the terms and conditions set forth in the RSU Agreement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of common stock at settlement subject to the terms and conditions set forth in the award of such RSUs by the Company to the Reporting Person pursuant to a Restricted Stock Unit Award Agreement (the \"RSU Agreement\"). The RSUs vest in four equal quarterly installments on September 21, 2021, December 21, 2021, March 21, 2022 and June 21, 2022, subject to the terms and conditions set forth in the RSU Agreement."}],"balance_after":2500,"derivative":{"underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001104659-21-144593","document":"tm2134159-1_4seq.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1558569/000110465921144593/tm2134159-1_4seq.xml","form_type":"4"}},{"id":2492938,"issuer":{"id":8372,"kind":"organization","name":"iSpecimen Inc."},"owners":[{"id":90805,"kind":"person","name":"Ross Andrew L.","position":1,"cik":"0001857013","reported_name":"Ross Andrew L.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Non-Qualified Stock Options","published_at":"2021-11-30T01:01:04.000Z","date":"2021-07-30","kind":"grant","acquired":true,"shares":13525,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each non-qualified stock option (\"NSO\") represents a contingent right to receive one share of common stock at settlement subject to the terms and conditions set forth in the award of such NSOs by iSpecimen Inc. (the \"Company\") to the Reporting Person pursuant to a Nonqualified Stock Option Award Agreement (the \"NSO Agreement\") under the iSpecimen Inc. 2021 Amended and Restated Stock Incentive Plan, as amended. The NSOs has a vesting term of three years with a one-year cliff (i.e. 33.33% of the NSOs vest on June 21, 2022, and the rest of the NSOs vest in equal quarterly installments on September 21, 2022 and each December 21, March 21, June 21 and September 21 until June 21, 2024), subject to the terms and conditions set forth in the NSO Agreement."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each non-qualified stock option (\"NSO\") represents a contingent right to receive one share of common stock at settlement subject to the terms and conditions set forth in the award of such NSOs by iSpecimen Inc. (the \"Company\") to the Reporting Person pursuant to a Nonqualified Stock Option Award Agreement (the \"NSO Agreement\") under the iSpecimen Inc. 2021 Amended and Restated Stock Incentive Plan, as amended. The NSOs has a vesting term of three years with a one-year cliff (i.e. 33.33% of the NSOs vest on June 21, 2022, and the rest of the NSOs vest in equal quarterly installments on September 21, 2022 and each December 21, March 21, June 21 and September 21 until June 21, 2024), subject to the terms and conditions set forth in the NSO Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The derivative securities were awarded as compensation to the Reporting Person for his service as the director of the Company."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each non-qualified stock option (\"NSO\") represents a contingent right to receive one share of common stock at settlement subject to the terms and conditions set forth in the award of such NSOs by iSpecimen Inc. (the \"Company\") to the Reporting Person pursuant to a Nonqualified Stock Option Award Agreement (the \"NSO Agreement\") under the iSpecimen Inc. 2021 Amended and Restated Stock Incentive Plan, as amended. The NSOs has a vesting term of three years with a one-year cliff (i.e. 33.33% of the NSOs vest on June 21, 2022, and the rest of the NSOs vest in equal quarterly installments on September 21, 2022 and each December 21, March 21, June 21 and September 21 until June 21, 2024), subject to the terms and conditions set forth in the NSO Agreement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each non-qualified stock option (\"NSO\") represents a contingent right to receive one share of common stock at settlement subject to the terms and conditions set forth in the award of such NSOs by iSpecimen Inc. (the \"Company\") to the Reporting Person pursuant to a Nonqualified Stock Option Award Agreement (the \"NSO Agreement\") under the iSpecimen Inc. 2021 Amended and Restated Stock Incentive Plan, as amended. The NSOs has a vesting term of three years with a one-year cliff (i.e. 33.33% of the NSOs vest on June 21, 2022, and the rest of the NSOs vest in equal quarterly installments on September 21, 2022 and each December 21, March 21, June 21 and September 21 until June 21, 2024), subject to the terms and conditions set forth in the NSO Agreement."}],"balance_after":13525,"derivative":{"underlying":"Common Stock","underlying_shares":13525},"source":{"system":"sec-edgar","filing":"0001104659-21-144593","document":"tm2134159-1_4seq.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1558569/000110465921144593/tm2134159-1_4seq.xml","form_type":"4"}},{"id":2492937,"issuer":{"id":8372,"kind":"organization","name":"iSpecimen Inc."},"owners":[{"id":90805,"kind":"person","name":"Ross Andrew L.","position":1,"cik":"0001857013","reported_name":"Ross Andrew L.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-11-30T01:01:04.000Z","date":"2021-11-16","kind":"purchase","acquired":true,"shares":1000,"price":5.19,"value":5190.0,"ownership":{"direct":false,"nature":"By Wingood Capital LLC"},"balance_after":1314524,"source":{"system":"sec-edgar","filing":"0001104659-21-144593","document":"tm2134159-1_4seq.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1558569/000110465921144593/tm2134159-1_4seq.xml","form_type":"4"}},{"id":2492936,"issuer":{"id":8372,"kind":"organization","name":"iSpecimen Inc."},"owners":[{"id":90805,"kind":"person","name":"Ross Andrew L.","position":1,"cik":"0001857013","reported_name":"Ross Andrew L.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-11-30T01:01:04.000Z","date":"2021-11-15","kind":"purchase","acquired":true,"shares":500,"price":5.3,"value":2650.0,"ownership":{"direct":true},"balance_after":1313524,"source":{"system":"sec-edgar","filing":"0001104659-21-144593","document":"tm2134159-1_4seq.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1558569/000110465921144593/tm2134159-1_4seq.xml","form_type":"4"}},{"id":2492935,"issuer":{"id":8372,"kind":"organization","name":"iSpecimen Inc."},"owners":[{"id":90805,"kind":"person","name":"Ross Andrew L.","position":1,"cik":"0001857013","reported_name":"Ross Andrew L.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-11-30T01:01:04.000Z","date":"2021-11-15","kind":"purchase","acquired":true,"shares":500,"price":5.29,"value":2645.0,"ownership":{"direct":true},"balance_after":1313024,"source":{"system":"sec-edgar","filing":"0001104659-21-144593","document":"tm2134159-1_4seq.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1558569/000110465921144593/tm2134159-1_4seq.xml","form_type":"4"}},{"id":2492934,"issuer":{"id":8372,"kind":"organization","name":"iSpecimen Inc."},"owners":[{"id":90805,"kind":"person","name":"Ross Andrew L.","position":1,"cik":"0001857013","reported_name":"Ross Andrew L.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-11-30T01:01:04.000Z","date":"2021-11-10","kind":"purchase","acquired":true,"shares":500,"price":5.85,"value":2925.0,"ownership":{"direct":true},"balance_after":1312524,"source":{"system":"sec-edgar","filing":"0001104659-21-144593","document":"tm2134159-1_4seq.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1558569/000110465921144593/tm2134159-1_4seq.xml","form_type":"4"}},{"id":2492933,"issuer":{"id":8372,"kind":"organization","name":"iSpecimen Inc."},"owners":[{"id":90805,"kind":"person","name":"Ross Andrew L.","position":1,"cik":"0001857013","reported_name":"Ross Andrew L.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-11-30T01:01:04.000Z","date":"2021-11-08","kind":"purchase","acquired":true,"shares":1000,"price":5.73,"value":5730.0,"ownership":{"direct":false,"nature":"By Wingood Capital LLC"},"balance_after":1312024,"source":{"system":"sec-edgar","filing":"0001104659-21-144593","document":"tm2134159-1_4seq.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1558569/000110465921144593/tm2134159-1_4seq.xml","form_type":"4"}},{"id":2492932,"issuer":{"id":8372,"kind":"organization","name":"iSpecimen Inc."},"owners":[{"id":90805,"kind":"person","name":"Ross Andrew L.","position":1,"cik":"0001857013","reported_name":"Ross Andrew L.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-11-30T01:01:04.000Z","date":"2021-06-23","kind":"purchase","acquired":true,"shares":400,"price":6.52,"value":2608.0,"ownership":{"direct":true},"balance_after":1311024,"source":{"system":"sec-edgar","filing":"0001104659-21-144593","document":"tm2134159-1_4seq.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1558569/000110465921144593/tm2134159-1_4seq.xml","form_type":"4"}},{"id":2492931,"issuer":{"id":8372,"kind":"organization","name":"iSpecimen Inc."},"owners":[{"id":90805,"kind":"person","name":"Ross Andrew L.","position":1,"cik":"0001857013","reported_name":"Ross Andrew L.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-11-30T01:01:04.000Z","date":"2021-06-17","kind":"purchase","acquired":true,"shares":100,"price":6.27,"value":627.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Including 1,310,524 shares of common stock acquired by the Reporting Person on June 21, 2021, as reported in the Form 4 filed with the Securities and Exchange Commission on June 23, 2021."}],"balance_after":1310624,"source":{"system":"sec-edgar","filing":"0001104659-21-144593","document":"tm2134159-1_4seq.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1558569/000110465921144593/tm2134159-1_4seq.xml","form_type":"4"}},{"id":2506406,"issuer":{"id":8372,"kind":"organization","name":"iSpecimen Inc."},"owners":[{"id":112896,"kind":"person","name":"Curley Tracy","position":1,"cik":"0001857028","reported_name":"Curley Tracy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-11-18T01:01:11.000Z","date":"2021-11-17","kind":"purchase","acquired":true,"shares":2000,"price":5.12,"value":10240.0,"ownership":{"direct":true},"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001104659-21-140720","document":"tm2133335-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1558569/000110465921140720/tm2133335-1_4seq1.xml","form_type":"4"}},{"id":2506405,"issuer":{"id":8372,"kind":"organization","name":"iSpecimen Inc."},"owners":[{"id":112896,"kind":"person","name":"Curley Tracy","position":1,"cik":"0001857028","reported_name":"Curley Tracy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-11-18T01:01:11.000Z","date":"2021-11-16","kind":"purchase","acquired":true,"shares":8000,"price":5.23,"value":41840.0,"ownership":{"direct":true},"balance_after":8000,"source":{"system":"sec-edgar","filing":"0001104659-21-140720","document":"tm2133335-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1558569/000110465921140720/tm2133335-1_4seq1.xml","form_type":"4"}},{"id":2656822,"issuer":{"id":8372,"kind":"organization","name":"iSpecimen Inc."},"owners":[{"id":90805,"kind":"person","name":"Ross Andrew L.","position":1,"cik":"0001857013","reported_name":"Ross Andrew L.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Bridge Note","published_at":"2021-06-24T01:35:54.000Z","date":"2021-06-21","kind":"exercise","acquired":false,"shares":13985,"ownership":{"direct":false,"nature":"By Andrew L. Ross 2013 Irrevocable Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The bridge note has a maturity date of June 30, 2021 and automatically converted into 13,985 shares of common stock at $5.60 upon the closing of the IPO."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"The bridge note has a maturity date of June 30, 2021 and automatically converted into 13,985 shares of common stock at $5.60 upon the closing of the IPO."}],"balance_after":0,"derivative":{"exercise_price":5.6,"expiration_date":"2021-06-30","underlying":"Common Stock","underlying_shares":13985},"source":{"system":"sec-edgar","filing":"0001104659-21-084775","document":"tm2120463-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1558569/000110465921084775/tm2120463-1_4seq1.xml","form_type":"4"}},{"id":2656821,"issuer":{"id":8372,"kind":"organization","name":"iSpecimen Inc."},"owners":[{"id":90805,"kind":"person","name":"Ross Andrew L.","position":1,"cik":"0001857013","reported_name":"Ross Andrew L.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Bridge Note","published_at":"2021-06-24T01:35:54.000Z","date":"2021-06-21","kind":"exercise","acquired":false,"shares":86438,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The bridge note has a maturity date of June 30, 2021 and automatically converted into 100,423 shares of common stock at $5.60 upon the closing of the IPO."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The bridge note has a maturity date of June 30, 2021 and automatically converted into 100,423 shares of common stock at $5.60 upon the closing of the IPO."}],"balance_after":0,"derivative":{"exercise_price":5.6,"expiration_date":"2021-06-30","underlying":"Common Stock","underlying_shares":86.438},"source":{"system":"sec-edgar","filing":"0001104659-21-084775","document":"tm2120463-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1558569/000110465921084775/tm2120463-1_4seq1.xml","form_type":"4"}},{"id":2656820,"issuer":{"id":8372,"kind":"organization","name":"iSpecimen Inc."},"owners":[{"id":90805,"kind":"person","name":"Ross Andrew L.","position":1,"cik":"0001857013","reported_name":"Ross Andrew L.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Bridge Note","published_at":"2021-06-24T01:35:54.000Z","date":"2021-06-21","kind":"other","acquired":true,"shares":39,"ownership":{"direct":false,"nature":"By Andrew L. Ross 2013 Irrevocable Trust"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F9","text":"The bridge note has a maturity date of June 30, 2021 and automatically converted into 13,985 shares of common stock at $5.60 upon the closing of the IPO."},{"field":"shares","element":"transactionShares","label":"F11","text":"Represents accrued interest from June 17, 2021 to June 21, 2021 under the bridge note."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The bridge note has a maturity date of June 30, 2021 and automatically converted into 13,985 shares of common stock at $5.60 upon the closing of the IPO."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"The bridge note has a maturity date of June 30, 2021 and automatically converted into 13,985 shares of common stock at $5.60 upon the closing of the IPO."}],"balance_after":13985,"derivative":{"expiration_date":"2021-06-30","underlying":"Common Stock","underlying_shares":39},"source":{"system":"sec-edgar","filing":"0001104659-21-084775","document":"tm2120463-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1558569/000110465921084775/tm2120463-1_4seq1.xml","form_type":"4"}},{"id":2656819,"issuer":{"id":8372,"kind":"organization","name":"iSpecimen Inc."},"owners":[{"id":90805,"kind":"person","name":"Ross Andrew L.","position":1,"cik":"0001857013","reported_name":"Ross Andrew L.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Bridge Note","published_at":"2021-06-24T01:35:54.000Z","date":"2021-06-21","kind":"other","acquired":true,"shares":2420,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F8","text":"The bridge note has a maturity date of June 30, 2021 and automatically converted into 100,423 shares of common stock at $5.60 upon the closing of the IPO."},{"field":"shares","element":"transactionShares","label":"F11","text":"Represents accrued interest from June 17, 2021 to June 21, 2021 under the bridge note."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The bridge note has a maturity date of June 30, 2021 and automatically converted into 100,423 shares of common stock at $5.60 upon the closing of the IPO."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The bridge note has a maturity date of June 30, 2021 and automatically converted into 100,423 shares of common stock at $5.60 upon the closing of the IPO."}],"balance_after":86438,"derivative":{"expiration_date":"2021-06-30","underlying":"Common Stock","underlying_shares":2420},"source":{"system":"sec-edgar","filing":"0001104659-21-084775","document":"tm2120463-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1558569/000110465921084775/tm2120463-1_4seq1.xml","form_type":"4"}},{"id":2656818,"issuer":{"id":8372,"kind":"organization","name":"iSpecimen Inc."},"owners":[{"id":90805,"kind":"person","name":"Ross Andrew L.","position":1,"cik":"0001857013","reported_name":"Ross Andrew L.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Convertible Note","published_at":"2021-06-24T01:35:54.000Z","date":"2021-06-21","kind":"exercise","acquired":false,"shares":360674,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The convertible note has a maturity date of June 30, 2021 and automatically converted into 360,674 shares of common stock at $5.60 upon the closing of the IPO."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The convertible note has a maturity date of June 30, 2021 and automatically converted into 360,674 shares of common stock at $5.60 upon the closing of the IPO."}],"balance_after":0,"derivative":{"exercise_price":5.6,"expiration_date":"2021-06-30","underlying":"Common Stock","underlying_shares":360674},"source":{"system":"sec-edgar","filing":"0001104659-21-084775","document":"tm2120463-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1558569/000110465921084775/tm2120463-1_4seq1.xml","form_type":"4"}},{"id":2656817,"issuer":{"id":8372,"kind":"organization","name":"iSpecimen Inc."},"owners":[{"id":90805,"kind":"person","name":"Ross Andrew L.","position":1,"cik":"0001857013","reported_name":"Ross Andrew L.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Convertible Note","published_at":"2021-06-24T01:35:54.000Z","date":"2021-06-21","kind":"other","acquired":true,"shares":231,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"The convertible note has a maturity date of June 30, 2021 and automatically converted into 360,674 shares of common stock at $5.60 upon the closing of the IPO."},{"field":"shares","element":"transactionShares","label":"F10","text":"Represents accrued interest from June 17, 2021 to June 21, 2021 under the convertible note."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The convertible note has a maturity date of June 30, 2021 and automatically converted into 360,674 shares of common stock at $5.60 upon the closing of the IPO."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The convertible note has a maturity date of June 30, 2021 and automatically converted into 360,674 shares of common stock at $5.60 upon the closing of the IPO."}],"balance_after":360674,"derivative":{"expiration_date":"2021-06-30","underlying":"Common Stock","underlying_shares":231},"source":{"system":"sec-edgar","filing":"0001104659-21-084775","document":"tm2120463-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1558569/000110465921084775/tm2120463-1_4seq1.xml","form_type":"4"}},{"id":2656816,"issuer":{"id":8372,"kind":"organization","name":"iSpecimen Inc."},"owners":[{"id":90805,"kind":"person","name":"Ross Andrew L.","position":1,"cik":"0001857013","reported_name":"Ross Andrew L.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Preferred Stock","published_at":"2021-06-24T01:35:54.000Z","date":"2021-06-21","kind":"exercise","acquired":false,"shares":130081,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"Shares of Series B Preferred Stock automatically converted into shares of common stock upon the closing of the IPO and has no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Shares of Series B Preferred Stock automatically converted into shares of common stock upon the closing of the IPO and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Shares of Series B Preferred Stock automatically converted into shares of common stock upon the closing of the IPO and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Shares of Series B Preferred Stock automatically converted into shares of common stock upon the closing of the IPO and has no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":130081},"source":{"system":"sec-edgar","filing":"0001104659-21-084775","document":"tm2120463-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1558569/000110465921084775/tm2120463-1_4seq1.xml","form_type":"4"}},{"id":2656815,"issuer":{"id":8372,"kind":"organization","name":"iSpecimen Inc."},"owners":[{"id":90805,"kind":"person","name":"Ross Andrew L.","position":1,"cik":"0001857013","reported_name":"Ross Andrew L.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Preferred Stock","published_at":"2021-06-24T01:35:54.000Z","date":"2021-06-21","kind":"exercise","acquired":false,"shares":355005,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Shares of Series A Preferred Stock automatically converted into shares of common stock upon the closing of the Issuer's initial public offering (the \"IPO) and has no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Shares of Series A Preferred Stock automatically converted into shares of common stock upon the closing of the Issuer's initial public offering (the \"IPO) and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Shares of Series A Preferred Stock automatically converted into shares of common stock upon the closing of the Issuer's initial public offering (the \"IPO) and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Shares of Series A Preferred Stock automatically converted into shares of common stock upon the closing of the Issuer's initial public offering (the \"IPO) and has no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":355005},"source":{"system":"sec-edgar","filing":"0001104659-21-084775","document":"tm2120463-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1558569/000110465921084775/tm2120463-1_4seq1.xml","form_type":"4"}},{"id":2656814,"issuer":{"id":8372,"kind":"organization","name":"iSpecimen Inc."},"owners":[{"id":90805,"kind":"person","name":"Ross Andrew L.","position":1,"cik":"0001857013","reported_name":"Ross Andrew L.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-06-24T01:35:54.000Z","date":"2021-06-21","kind":"exercise","acquired":true,"shares":13985,"ownership":{"direct":false,"nature":"By Andrew L. Ross 2013 Irrevocable Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Shares were issued to the reporting person upon conversion of an aggregate of $562,375 in principal and accrued interest through June 21, 2021 under a bridge note owed to the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Shares were issued to the reporting person upon conversion of an aggregate of $562,375 in principal and accrued interest through June 21, 2021 under a bridge note owed to the reporting person."}],"balance_after":1310524,"source":{"system":"sec-edgar","filing":"0001104659-21-084775","document":"tm2120463-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1558569/000110465921084775/tm2120463-1_4seq1.xml","form_type":"4"}},{"id":2656813,"issuer":{"id":8372,"kind":"organization","name":"iSpecimen Inc."},"owners":[{"id":90805,"kind":"person","name":"Ross Andrew L.","position":1,"cik":"0001857013","reported_name":"Ross Andrew L.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-06-24T01:35:54.000Z","date":"2021-06-21","kind":"exercise","acquired":true,"shares":86438,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Shares were issued to the reporting person upon conversion of an aggregate of $562,375 in principal and accrued interest through June 21, 2021 under a bridge note owed to the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Shares were issued to the reporting person upon conversion of an aggregate of $562,375 in principal and accrued interest through June 21, 2021 under a bridge note owed to the reporting person."}],"balance_after":1296539,"source":{"system":"sec-edgar","filing":"0001104659-21-084775","document":"tm2120463-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1558569/000110465921084775/tm2120463-1_4seq1.xml","form_type":"4"}},{"id":2656812,"issuer":{"id":8372,"kind":"organization","name":"iSpecimen Inc."},"owners":[{"id":90805,"kind":"person","name":"Ross Andrew L.","position":1,"cik":"0001857013","reported_name":"Ross Andrew L.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-06-24T01:35:54.000Z","date":"2021-06-21","kind":"exercise","acquired":true,"shares":360674,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Shares were issued to the reporting person upon conversion of an aggregate of $2,019,797 in principal and accrued interest through June 21, 2021 under a convertible note owed to the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Shares were issued to the reporting person upon conversion of an aggregate of $2,019,797 in principal and accrued interest through June 21, 2021 under a convertible note owed to the reporting person."}],"balance_after":1210101,"source":{"system":"sec-edgar","filing":"0001104659-21-084775","document":"tm2120463-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1558569/000110465921084775/tm2120463-1_4seq1.xml","form_type":"4"}},{"id":2656811,"issuer":{"id":8372,"kind":"organization","name":"iSpecimen Inc."},"owners":[{"id":90805,"kind":"person","name":"Ross Andrew L.","position":1,"cik":"0001857013","reported_name":"Ross Andrew L.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-06-24T01:35:54.000Z","date":"2021-06-21","kind":"exercise","acquired":true,"shares":130081,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares were issued to the reporting person upon conversion of the Issuer's Series B Preferred Stock owned through the date of conversion."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Shares were issued to the reporting person upon conversion of the Issuer's Series B Preferred Stock owned through the date of conversion."}],"balance_after":849427,"source":{"system":"sec-edgar","filing":"0001104659-21-084775","document":"tm2120463-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1558569/000110465921084775/tm2120463-1_4seq1.xml","form_type":"4"}},{"id":2656810,"issuer":{"id":8372,"kind":"organization","name":"iSpecimen Inc."},"owners":[{"id":90805,"kind":"person","name":"Ross Andrew L.","position":1,"cik":"0001857013","reported_name":"Ross Andrew L.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-06-24T01:35:54.000Z","date":"2021-06-21","kind":"exercise","acquired":true,"shares":355005,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares were issued to the reporting person upon conversion of the Issuer's Series A Preferred Stock owned through the date of conversion."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Shares were issued to the reporting person upon conversion of the Issuer's Series A Preferred Stock owned through the date of conversion."}],"balance_after":719346,"source":{"system":"sec-edgar","filing":"0001104659-21-084775","document":"tm2120463-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1558569/000110465921084775/tm2120463-1_4seq1.xml","form_type":"4"}},{"id":2656808,"issuer":{"id":8372,"kind":"organization","name":"iSpecimen Inc."},"owners":[{"id":113386,"kind":"person","name":"Mullan Jill","position":1,"cik":"0001857039","reported_name":"Mullan Jill","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO, Secretary, Treasurer"}}],"security":"Bridge Note","published_at":"2021-06-24T01:23:55.000Z","date":"2021-06-21","kind":"exercise","acquired":false,"shares":76897,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The bridge note has a maturity date of June 30, 2021 and automatically converted into 76,897 shares of common stock at $5.60 upon the closing of the IPO."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The bridge note has a maturity date of June 30, 2021 and automatically converted into 76,897 shares of common stock at $5.60 upon the closing of the IPO."}],"balance_after":0,"derivative":{"exercise_price":5.6,"expiration_date":"2021-06-30","underlying":"Common Stock","underlying_shares":76897},"source":{"system":"sec-edgar","filing":"0001104659-21-084773","document":"tm2120463-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1558569/000110465921084773/tm2120463-3_4seq1.xml","form_type":"4"}},{"id":2656807,"issuer":{"id":8372,"kind":"organization","name":"iSpecimen Inc."},"owners":[{"id":113386,"kind":"person","name":"Mullan Jill","position":1,"cik":"0001857039","reported_name":"Mullan Jill","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO, Secretary, Treasurer"}}],"security":"Bridge Note","published_at":"2021-06-24T01:23:55.000Z","date":"2021-06-21","kind":"other","acquired":true,"shares":255,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"The bridge note has a maturity date of June 30, 2021 and automatically converted into 76,897 shares of common stock at $5.60 upon the closing of the IPO."},{"field":"shares","element":"transactionShares","label":"F5","text":"Represents accrued interest from June 17, 2021 to June 21, 2021 under the bridge note."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The bridge note has a maturity date of June 30, 2021 and automatically converted into 76,897 shares of common stock at $5.60 upon the closing of the IPO."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The bridge note has a maturity date of June 30, 2021 and automatically converted into 76,897 shares of common stock at $5.60 upon the closing of the IPO."}],"balance_after":76897,"derivative":{"expiration_date":"2021-06-30","underlying":"Common Stock","underlying_shares":255},"source":{"system":"sec-edgar","filing":"0001104659-21-084773","document":"tm2120463-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1558569/000110465921084773/tm2120463-3_4seq1.xml","form_type":"4"}},{"id":2656806,"issuer":{"id":8372,"kind":"organization","name":"iSpecimen Inc."},"owners":[{"id":113386,"kind":"person","name":"Mullan Jill","position":1,"cik":"0001857039","reported_name":"Mullan Jill","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO, Secretary, Treasurer"}}],"security":"Series A Preferred Stock","published_at":"2021-06-24T01:23:55.000Z","date":"2021-06-21","kind":"exercise","acquired":false,"shares":6250,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Shares of Series A Preferred Stock automatically converted into shares of common stock upon the closing of the Issuer's initial public offering (the \"IPO) and has no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Shares of Series A Preferred Stock automatically converted into shares of common stock upon the closing of the Issuer's initial public offering (the \"IPO) and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Shares of Series A Preferred Stock automatically converted into shares of common stock upon the closing of the Issuer's initial public offering (the \"IPO) and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Shares of Series A Preferred Stock automatically converted into shares of common stock upon the closing of the Issuer's initial public offering (the \"IPO) and has no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":6250},"source":{"system":"sec-edgar","filing":"0001104659-21-084773","document":"tm2120463-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1558569/000110465921084773/tm2120463-3_4seq1.xml","form_type":"4"}},{"id":2656805,"issuer":{"id":8372,"kind":"organization","name":"iSpecimen Inc."},"owners":[{"id":113386,"kind":"person","name":"Mullan Jill","position":1,"cik":"0001857039","reported_name":"Mullan Jill","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO, Secretary, Treasurer"}}],"security":"Common Stock","published_at":"2021-06-24T01:23:55.000Z","date":"2021-06-21","kind":"exercise","acquired":true,"shares":76897,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares were issued to the reporting person upon conversion of an aggregate of $430,625 in principal and  accrued  interest through June 21, 2021 under a bridge note owed to the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Shares were issued to the reporting person upon conversion of an aggregate of $430,625 in principal and  accrued  interest through June 21, 2021 under a bridge note owed to the reporting person."}],"balance_after":126463,"source":{"system":"sec-edgar","filing":"0001104659-21-084773","document":"tm2120463-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1558569/000110465921084773/tm2120463-3_4seq1.xml","form_type":"4"}},{"id":2656804,"issuer":{"id":8372,"kind":"organization","name":"iSpecimen Inc."},"owners":[{"id":113386,"kind":"person","name":"Mullan Jill","position":1,"cik":"0001857039","reported_name":"Mullan Jill","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO, Secretary, Treasurer"}}],"security":"Common Stock","published_at":"2021-06-24T01:23:55.000Z","date":"2021-06-21","kind":"exercise","acquired":true,"shares":6250,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares were issued to the reporting person upon conversion of the Issuer's Series A Preferred Stock owned through the date of conversion."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Shares were issued to the reporting person upon conversion of the Issuer's Series A Preferred Stock owned through the date of conversion."}],"balance_after":49566,"source":{"system":"sec-edgar","filing":"0001104659-21-084773","document":"tm2120463-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1558569/000110465921084773/tm2120463-3_4seq1.xml","form_type":"4"}},{"id":2656803,"issuer":{"id":8372,"kind":"organization","name":"iSpecimen Inc."},"owners":[{"id":113384,"kind":"person","name":"Ianelli Christopher","position":1,"cik":"0001857027","reported_name":"Ianelli Christopher","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, President"}}],"security":"Series A Preferred Stock","published_at":"2021-06-23T23:59:41.000Z","date":"2021-06-21","kind":"exercise","acquired":false,"shares":2663,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Shares of Series A Preferred Stock automatically converted into shares of common stock upon the closing of the Issuer's initial public offering and has no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Shares of Series A Preferred Stock automatically converted into shares of common stock upon the closing of the Issuer's initial public offering and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares of Series A Preferred Stock automatically converted into shares of common stock upon the closing of the Issuer's initial public offering and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Shares of Series A Preferred Stock automatically converted into shares of common stock upon the closing of the Issuer's initial public offering and has no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2663},"source":{"system":"sec-edgar","filing":"0001104659-21-084750","document":"tm2120463-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1558569/000110465921084750/tm2120463-2_4seq1.xml","form_type":"4"}},{"id":2656802,"issuer":{"id":8372,"kind":"organization","name":"iSpecimen Inc."},"owners":[{"id":113384,"kind":"person","name":"Ianelli Christopher","position":1,"cik":"0001857027","reported_name":"Ianelli Christopher","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, President"}}],"security":"Common Stock","published_at":"2021-06-23T23:59:41.000Z","date":"2021-06-21","kind":"exercise","acquired":true,"shares":2663,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares were issued to the reporting person upon conversion of the Issuer's Series A Preferred Stock owned through the date of conversion."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Shares were issued to the reporting person upon conversion of the Issuer's Series A Preferred Stock owned through the date of conversion."}],"balance_after":343357,"source":{"system":"sec-edgar","filing":"0001104659-21-084750","document":"tm2120463-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1558569/000110465921084750/tm2120463-2_4seq1.xml","form_type":"4"}},{"id":2656801,"issuer":{"id":8372,"kind":"organization","name":"iSpecimen Inc."},"owners":[{"id":137953,"kind":"organization","name":"OBF Investments, LLC","position":1,"cik":"0001857012","reported_name":"OBF Investments, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":117036,"kind":"person","name":"Scholl George H.","position":2,"cik":"0001857026","reported_name":"Scholl George H.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Bridge Note","published_at":"2021-06-23T23:58:51.000Z","date":"2021-06-21","kind":"exercise","acquired":false,"shares":119035,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The bridge note has a maturity date of June 30, 2021 and automatically converted into 119,035 shares of common stock at $5.60 upon the closing of the IPO."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The bridge note has a maturity date of June 30, 2021 and automatically converted into 119,035 shares of common stock at $5.60 upon the closing of the IPO."}],"balance_after":0,"derivative":{"exercise_price":5.6,"expiration_date":"2021-06-30","underlying":"Common Stock","underlying_shares":119035},"source":{"system":"sec-edgar","filing":"0001104659-21-084748","document":"tm2120463-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1558569/000110465921084748/tm2120463-4_4seq1.xml","form_type":"4"}},{"id":2656800,"issuer":{"id":8372,"kind":"organization","name":"iSpecimen Inc."},"owners":[{"id":137953,"kind":"organization","name":"OBF Investments, LLC","position":1,"cik":"0001857012","reported_name":"OBF Investments, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":117036,"kind":"person","name":"Scholl George H.","position":2,"cik":"0001857026","reported_name":"Scholl George H.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Bridge Note","published_at":"2021-06-23T23:58:51.000Z","date":"2021-06-21","kind":"other","acquired":true,"shares":364,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"The bridge note has a maturity date of June 30, 2021 and automatically converted into 119,035 shares of common stock at $5.60 upon the closing of the IPO."},{"field":"shares","element":"transactionShares","label":"F9","text":"Represents accrued interest from June 17, 2021 to June 21, 2021 under the bridge note"},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The bridge note has a maturity date of June 30, 2021 and automatically converted into 119,035 shares of common stock at $5.60 upon the closing of the IPO."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The bridge note has a maturity date of June 30, 2021 and automatically converted into 119,035 shares of common stock at $5.60 upon the closing of the IPO."}],"balance_after":119035,"derivative":{"expiration_date":"2021-06-30","underlying":"Common Stock","underlying_shares":364},"source":{"system":"sec-edgar","filing":"0001104659-21-084748","document":"tm2120463-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1558569/000110465921084748/tm2120463-4_4seq1.xml","form_type":"4"}}],"next_cursor":"2021-06-23T23:58:51.000000Z,2656800"}